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ABSTRACT

INVESTIGATING THE ROLE OF HISTONE H2A PROTEOLYSIS DURING STEM CELL
DIFFERENTIATION
Mariel Coradin
Benjamin A. Garcia

Histone proteolysis is a poorly understood phenomenon in which the N-terminal tails of
histones are irreversible cleaved by intracellular proteases. During development, histone posttranslational modifications are known to orchestrate gene expression patterns that ultimately drive
cell fate decisions. Therefore, deciphering the mechanisms of histone proteolysis is necessary to
enhance the understanding of cellular differentiation. Here we show that H2A is cleaved by the
lysosomal protease Cathepsin L during ESCs differentiation. Using quantitative mass spectrometry
(MS), we identified L23 to be the primary cleavage site that gives rise to the clipped form of H2A
(cH2A), which reaches a maximum level of ~1% of total H2A after 4 days of differentiation. Using
ChIP-seq, we found that preventing proteolysis leads to an increase in acetylated H2A at promoter
regions in differentiated ES cells. We also report novel readers of acetylated H2A in pluripotent ES
cells, including members of the pBAF complex, which recognize distinct forms of H2A acetylation.
Finally, we show that H2A proteolysis abolishes this recognition. Altogether, our data suggest that
proteolysis serves as an efficient mechanism to silence pluripotency genes and destabilize the
nucleosome core particle.

v

TABLE OF CONTENTS
ACKNOWLEDMENTS……………………………………………………………………………………iii
ABSTRACT……………………………………………………………………………………….……….iv
LIST OF ILLUSTRATIONS………………………………………………………………………………x
CHAPTER 1: INTRODUCTION……………………...…………………..………………………………1
1.1 Epigenetics overview……………………………………………………………………………………………..1
1.2 Cellular proteases and histone proteolysis……………………………………………………………...……..4
1.3 Epigenetic regulation during stem cells differentiation ……………………………………………...………..6
1.4 Mass spectrometry as tool to interrogate chromatin biology ………………………………………………...9
1.5 References………………………………………………………………………………………………………..15

CHAPTER 2: Cleavage of histone H2A during embryonic stem cell differentiation
destabilizes nucleosomes to counteract gene activation………………………………………..26
2.1 Introduction …………………………………………………………………………………………...26
2.2 Results…………………………………………………………………………………………………28
2.2.1The N-terminal tail of histone H2A is cleaved during mouse embryonic stem cell
differentiation ……………………………………………………………………………..……..28
2.2.2 Cathepsin L facilitates H2A proteolysis upon cellular differentiation ……………….31
2.2.3 Knockdown CTSL leads to genome wide redistribution of acetylated H2A in stem
cells ……………………………………………………………………………………………….34
2.2.4 Acetylated H2A is recognized by pBAF complex in mESCs…………………………37
2.2.5 H2A proteolysis prevents PBAF recognition of acetylated H2A……………………..39
2.2.6 cH2A is associated with marks of active transcription and fast turnover…………...41
2.3 Discussion ………………………………………………………………………………………….....43
2.4. Materials and method ……………………………………………………………………………….47
2.4.1 Cell culture ………………………………………………………………………………..47
2.4.2 Histone isolation and nuclear extraction ……………………………………………….48
2.4.3 Co-immunoprecipiation (Co-Ips) and protein identification by Mass Spectrometry…49
2.4.4 Mononucleosme IP and histone PTMs ID by MS……………………………………...50
2.4.5 Peptide pulldowns and protein identification by MS…………………………..………..51
2.4.6 H2A Top-down analysis ………………………………………………………………….52
2.4.7 Quantitative Proteomics with multiple reaction monitoring (MRM) of H2A
acetylation……………………………………………………………………………..…………53
2.4.8 Chromatin immunoprecipitation followed by sequencing (ChIP-seq)…………….…53
2.4.9 Whole transcriptome analysis by RNA-seq…………………………………………….54
2.4.10 Go analysis and data availability ……………………………………………………...55

vi

2.5 References …………………………………………………………………………………………....56
2.6 Supplementary figures …………………………………………………………………………….…64
2.7 Supplementary tables ……………………………………………………………………………..…70
CHAPTER 3: Bullet points to evaluate the performance of the middle-down proteomics
workflow for histone modification analysis………………………...……………………...………72
3.1 Introduction ……………………………………………………………………………..………..…..72
3.2 Results ………….……………………………………………………………………….….…….…..75
3.2.1 Utilization of porous graphitic carbon (PGC) in the desalting step………...………..77
3.2.2 Re-evaluation of WCX mobile phase…………..……………………….……………...78
3.2.4 Determining proper fragmentation……………………………………….……………...80
3.2.4 Data visualization and interpretation…………………………………………………....81
3.3 Discussion ………………………………………………………………………………………….…81
3.4 Materials and methods………………………………………………………………………...…….83
3.4.1 Sample preparation and digestion with GluC…………………………………...….....83
3.4.2 sample desalting by StageTips…………………………………………………...…….84
3.4.3 Nano LC (nLC) configuration for middle-down ………………………………....…….84
3.4.4 MS/MS anlaysis……….………………………………………………………………….84
3.4.5 Data analysis…………………………………………………………………………...…85
3.5 References ……………….………………………………………………………………………..…86
CHAPTER 4: Conclusions and future directions. ………………………………………..………..91
4.1 Summary and main findings………………………………………………………..………91
4.2 Future directions …………………………………………………………………………….94
4.2.1 Histone proteolysis on H2A variants ………………………………………….94
4.2.2 Cathepsin L recruitment to chromatin in ESCs…………….…………………95
4.2.3 Genome wide localization of PBAF upon proteolysis….…………………….96
4.2.4 What happens after nucleosome eviction?..... …….…………………………96
4.2.5 New developments in Middle-Down MS………………………………………97
4.3 References ….……………………………………………………………………………….99

vii

LIST OF ILLUSTRATIONS
Figure 1.1 Schematic representation of nucleosome core particle…………………………………..1
Figure 1.2 Gene regulation by histone acetylation………………………………………………...…..2
Figure 1.3. Schematic representation of protease recognition and nomenclature system………..5
Figure 1.4 Histone proteolysis leads to tailless nucleosomes………………………………………...7
Figure 1.5 Schematic showing the preimplantation process in mice ………………….……………8
Figure 1.6 Composition of esBAF and npBAF…….……………………………………………………9
Figure 1.7 General schematic of histone bottom-up MS analysis………………………………..…11
Figure 1.8 Illustration of histone PTM crosstalk in H3. ………………………………………………12
Figure 2.1. Histone H2A is cleaved during ES cells differentiation…………………………………30
Figure 2.2. Cathepsin L facilitates H2A proteolysis upon differentiation…………………………..33
Figure 2.3. Genome wide localization of acetylated H2A……………………………………………36
Figure 2.4 Members of PBAF recognized acetylated H2A. …………………………………………38
Figure 2.5 H2A proteolysis prevents PBAF recognition of acetylated H2A………………………..40
Figure 2.6. cH2A is associated with marks of active transcription and fast turnover……………..42
Figure 2.7. Prosed model of gene regulation by H2A proteolysis. ………………………………...47
Supplementary figure 2.1……………………………………………………………..….…..65
Supplementary figure 2.2.. …………………………………………………………………..66
Supplementary figure 2.3……………………………………………………………..….…..67
Supplementary figure 2.4……………………………………………………………..….…..68
Supplementary figure 2.5. ……………………………………………………………..…….69
Figure 3.1. Current workflows to analyze histone post-translational modifications……………….73
Figure 3.2. StageTip comparison to assess sample loss prior to MS/MS analysis……………….76
Figure 3.3. Evaluation of middle-down chromatography……………………………………………..78
Figure 3.4. Evaluation of ETD fragmentation………………………………………………………….79
Figure 3.5. Assessing data quality……………………………………………………………………...80
Figure 3.6. Data visualization…………………………………………………………………………..81
Figure 4.1 Middle-down MS in literature……………………………………………………………….98

viii

INTRODUCTION
1.1 Epigenetics overview
Epigenetics is traditionally defined as changes in gene expression patterns that cannot be
traced to the underline DNA sequence. Such changes must be passed through generations to be
considered an epigenetic trait. (Allis and Jenuwein, 2016; Lind and Spagopoulou, 2018). To
orchestrate gene expression, histone proteins act like a control panel. Eukaryotic cells condense
their DNA into nucleosomes consisting of two copies of histone H3-H4 tetramers and two copies of
H2A-H2B dimers wrapped around approximately 150bp of DNA (Mariño-Ramírez et al., 2005;
Strahl and Allis, 2000) (Figure 1.1). As one can imagine, the nucleosome is a physical barrier for
the transcriptional machinery, therefore another level regulation is needed to rearrange these
nucleosomes to allow gene activation (Jiang and Pugh, 2009). Histones are very basic proteins,
providing a docking site for negatively charged DNA, however these interactions can be weakened
by small chemical moieties added to histones across their entire sequence (Müller and Muir, 2015).

H2B

H2A

H3

H4

DNA

Figure 1.1 Schematic representation of nucleosome core particle. The nucleosome consists
of two copies of each histone; H2A (yellow), H2B (green), H3 (blue), H4 (pink), and ~ 150 base
pairs of DNA (navy blue).

Histone tails (1-30a.a) are the major acceptors of post translational modifications (PTMs);
acetylation, methylation and phosphorylation are among the most common PTMs found in histone
tails (Peterson and Laniel, 2004).
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Histone acetylation occurs primarily in lysine resides, which neutralizes the positively
charged residues and provides a more open and relax chromatin environment known as
euchromatin (Gorisch, 2005). Acetylation has been correlated with gene activation. Recently, it has
been demonstrated that histone can modified with other forms of acylation such as succinylation,
crotonylation , butyrylation and glutatylation (Simithy et al., 2017).

Histone acetylation is catalyzed by histone acetyl transferases (HAT) that utilize acetyl-coA
as a precursor to modify the ε-amino group of lysine residues (Marmorstein and Zhou, 2014). HATs
have been shown to play a key role in gene regulation and their abnormal expression has been
implicated in several human diseases and aberrant cellular differentiation (Saraiva et al., 2010;
Wang et al., 2014). In cancer for example, mutation in HATs have been shown to stimulate tumor
growth (Wapenaar and Dekker, 2016). Furthermore, mutations in the histone acetyltransferase
CBP has been linked to developmental diseases, and several types of cancers such as, ovarian,
breast and lung (Di Martile et al., 2016).

Figure 1.2 Gene regulation by histone acetylation. Figure taken from (Verdin and Ott, 2015)
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Histone acetylation is removed by a set of proteins called histone deacetylases (HDAC),
and these proteins generally have more than one substrate and their specificity is guided by
interacting partners (Delcuve et al., 2012). HDACs utilize zinc or NAD+ to remove the acetyl moiety
on lysine residues (Seto and Yoshida, 2014), and once histones are deacetylated, the chromatin
tend to condense back to its basal closed state (Gallinari et al., 2007). Similar to HATs, HDACs
dysregulation have been linked to several types of cancers such as liver, pancreatic, breast and
neuroblastoma (Li and Seto, 2016). The underlining mechanism of these malignancies is typically
associated with histone hyperacetylation, highlighting the importance of a proper balance of histone
acetylation and deacetylation.

Another well studied mark is histone methylation. Contrary to acetylation, histone
methylation has been widely correlated with gene silencing (Strahl and Allis, 2000). Histones can
be mono, di and tri-methylated at lysine and arginine residues. Lysine methylation is catalyzed by
lysine methyltransferases (HKMTs), proteins that transfer a methyl group from S-adenosylmethine
(SAM) to the ε-amino group lysine residues (Bannister and Kouzarides, 2011). Arginine methylation
on the other hand, is catalyzed by arginine methyltransferase (PRMTs). These proteins also use
SAM as a methyl donor for the ω-guanidino group of arginine residues (Bannister and Kouzarides,
2011; Bedford and Clarke, 2009). Histone methylation is often found at inactive genomic regions
known as heterochromatin (Bannister et al., 2002). There are two types of heterochromatin that
can be defined by the presence of different histone modifications and chromatin interacting
proteins. Constitutive heterochromatin, for example is enriched with histone H3 lysine 9 trimethylation (H3K9me3) and several heterochromatin binding proteins (Rountree and Selker,
2010), while facultative heterochromatin is usually defined by the presence of H3K27me3 (Wiles
and Selker, 2017).

Interestingly, histone methylation can also be associated with gene activation, for instance
methylation of H3K4 is known to mark active promoters and methylation on H3K36 is typically
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associated with active transcription (Sims and Reinberg, 2006). Similar to histone acetylation,
histone methylation is also a reversible modification that is removed by histone demethylases
(Hyun et al., 2017). In the epigenetics field, proteins that catalyze the addition of chemical moieties
to histones are broadly known as “writers”, while those involved in the removal of such marks are
known as “erasers”.

Histone PTMs can also control gene regulation by recruiting chromatin binding proteins
and chromatin remodelers (Zhang et al., 2016). Acetylated lysine residues are recognized or read
by bromodomain containing proteins , while methylated residues serve as docking site for proteins
containing PHD, WD40, Tudor or chromo domains (Yun et al., 2011). Proteins that recognize
modified residues are called “readers”. Histone readers can recruit binding partners to regulate
gene expression. H3K9 methylation for example is read by HP1 and promotes heterochromatin
spreading (Wang et al., 2016). Some readers recruit proteins that are able to induce conformational
changes by sliding the nucleosome and even ejecting them from chromatin. This is the case for
chromatin remodelers which use ATP to physically modify chromatin structure (Längst and
Manelyte, 2015). Often chromatin remodelers contain reader domains such as bromodomains that
are able to bind directly to histone proteins (Horn and Peterson, 2001). By rearranging
nucleosomes, chromatin remodels allow transcriptional activation by allowing access to the
underlying DNA. Moreover, these proteins are known to be essential in DNA repair, nucleosome
eviction and histone variant replacement (Chen et al., 2017).

1.2 Cellular protases and histone proteolysis
Making up approximately 1.3% of the human proteome (van den Berg and Tholey, 2012),
cellular proteases are known to be involved in several biological processes such as cell cycle
regulation, inflammation, apoptosis, embryonic development and cell migration (Puente et al.,
2003) . Proteolytic cleavage is driven by substrate recognition through the protease’s binding
pocket (Turk et al., 2001).
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Based on this principle, Berger and Schechter developed a nomenclature system where
the substrate residues around the protease-binding pocket are denoted as P4-P3-P2-P1↓P1′-P2′P3′-P4′ (Figure 1.3). The arrow indicates that the cleavage occurs between residues P1 and P1′
(Berger and Schechter, 1970; Impens et al., 2010). Cellular proteases can be grouped into 5 distinct
families according to their catalytic mechanism. While threonine, cysteine, and serine proteases
utilize an amino acid (Thr, Cys, or Ser) in their binding pocket to catalyze peptide cleavage, aspartic
and metalloproteases use water molecules as nucleophiles to cleave substrate peptide bonds
(Puente et al., 2003). Both serine proteases and metalloproteases, have been reported to cleaved
histone tails through unique processes.

Cleavage site

N

P3

P2

P1

P1’

P2’

C

Protease
Figure 1.3. Schematic representation of protease recognition and nomenclature system.
Figure adapted from (Coradin et al., 2017)

Histone tails, a critical component of nucleosomes, are largely dynamic, unstructured and
are major acceptors of PTMs. As previously described, most PTMs are reversible, however histone
proteolysis is permanent. Previously, histone tails have been observed to be enzymatically cleaved
and this process has been termed “histone clipping.” Chromatin proteases were first described in
1970, however it was not until the 1990s when histone proteolysis was described in Lin et al. where
they found that the removal of n-termini of the core histones was required for macronuclei
development in Tetrahymena (Lin et al., 1991). Beyond this, histone proteolysis or clipping has
been shown in organisms such as mouse, chicken, sea urchin, and human (Azad et al., 2018).
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In 2008, Duncan and colleagues first reported that the lysosomal protease Cathepsin L
cleaves histone H3 during mouse stem cell differentiation (Duncan et al., 2008a). More recently the
An group demonstrated that the matrix metalloproteinase 9 (MMP-9) cleaves H3 during
osteoclastogenesis. Interestingly, they also found that H3K18ac facilitates MMP-9 proteolysis,
suggesting a possible cross-talk between histone PTMs and proteolysis (Kim et al., 2016).
Additionally, Jumonji-C domain-containing protein 5 (JMJD5) have been reported to cleave
different monomethylated residues on H3 (K4, K9, K27) during DNA damage (Shen et al., 2017).
Methylated arginines on histone H3 have also been reported to be cleaved by JMJD5 and JMJD7
(Liu et al., 2017). Furthermore, not only canonical histone H3 have been shown to undergo
proteolysis, but also histone variants. In 2014, Duarte and colleagues found the histone variant
H3.3 is cleaved during cellular senescence by Cathepsin L to silence cell cycle genes (Duarte et
al., 2014).
Besides H3, histone H2A has been also shown to be cleaved in several biological contexts.
Neutrophil elastase (NE) was found to cleave H2A at the c-terminus (V114) in myeloid cells
(Dhaenens et al., 2014), and also in the context of chronic lymphocyte leukemia (Glibert et al.,
2014). Furthermore, histone H2B has been shown to be cleaved in human hepatocytes
(Tvardovskiy et al., 2015) and mast cells (Melo et al., 2014). Taken together, these reports suggest
that regulated proteolysis may be involved in gene transcription and epigenetic regulation by
altering histone modification profiles. As shown in Figure 1.4, following histone proteolysis,
chromatin modifier enzymes are no longer able to recognize histone PTMs, but the current
mechanism that drives histone proteolysis remains unclear.
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Figure 1.4 Histone proteolysis leads to tailless nucleosomes. Histone PTMs readout is lost
upon proteolysis. Histone H3 tail is shown in blue, yellow polygons represent PTMs in the tail, red
scissors indicate proteolysis and different chromatin modifiers proteins are shown in gray. Figure
adapted from (Azad et al., 2018)

1.3 Epigenetic regulation during stem cells differentiation
Embryonic stem cells (ESCs) are originated from the inner cell mass (ICM) of embryos in the
blastocyte stage (Keller, 2005). After fertilization, several rounds of cell division are required before
preimplantation. In mammals this process starts once the egg is fertilized and lasts until the
blastocyte is implanted in the uterus (Cockburn and Rossant, 2010). In the blastocyte stage, ESCs
express several transcription factors such as Nanog and Oct4, which are known to be associated
with pluripotency maintenance (Czechanski et al., 2014). Once ESCs are extracted from the
blastocyte, under the correct conditions they can be cultured indefinitely and still maintain the ability
to differentiate into different lineages (Reubinoff et al., 2000). Commonly, ESCs are cultured in
presence of the cytokine Leukemia inhibitory factor (LIF), which activates several pathways
including JAK-Stat3 and PI3K-Akt to drive the expression of pluripotency related genes (Ohtsuka
et al., 2015).
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Figure 1.5 Schematic showing the preimplantation process in mice. After several rounds
cell cycle totipotent blastomere (shown in beige) compact together to form the blastocyst (Nichols
and Smith, 2009). Figure taken from (Czechanski et al., 2014).

As illustrated in Figure 1.5, ESCs can be differentiated into all somatic linages (mesoderm,
endoderm, and ectoderm) (Romito and Cobellis, 2016). Differentiation is highly regulated by
external signals and internal factors such as epigenetic modulators and transcription factors (Mas
et al., 2018). Ectoderm differentiation is regulated by the activity of the bone morphogenic protein
(BMP) and the activation of several signaling pathways such as Wnt, ß-catenin and NF-kB (Qu et
al., 2016). Moreover, epigenetic changes are known to direct lineage commitment by altering gene
expression (Dixon et al., 2015; Giadrossi et al., 2007a). Undifferentiated cells are known to have a
more accessible and less compact chromatin than differentiated cells (Atlasi and Stunnenberg,
2017). These physical changes are driven by ATP-dependent chromatin remodelers acting to
reposition nucleosomes and/or promote histone variant exchange (Biran and Meshorer, 2012) and
global changes in histone PTMs (Giadrossi et al., 2007a).

During development ATP-dependent chromatin remodelers are essential in chromatin
assembly and disassembly (Ho and Crabtree, 2010). One of the best characterized chromatin
remodeler complex in development is the SWI/SNF (switch/sucrose non-fermentable) also known
as brahma-associated factor (BAF).
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This complex (~1.5 MDa) contains more than 15 subunits differently regulated through
development (Hota and Bruneau, 2016). As ESCs differentiate, the BAF complex undergoes
subunit exchange to regulate cell identity, for instance ES cells express esBAF which is essential
for pluripotency and self-renewal (Kadoch and Crabtree, 2015) while neural progenitor express
npBAF. As illustrated in Figure 1.6, esBAF contains BAF155 while npBAF contains BAF170.
Furthermore, knockout of the ATPase module BRG1 (common in all BAF complexes) is known to
be embryonically lethal in mice as is require for zygote genome activation and neuronal
differentiation (Bultman et al., 2000, 2006), highlighting the importance of chromatin remodeling in
pluripotency and development.

esBAF

npBAF

Figure 1.6 Composition of esBAF and npBAF. Figure adapted from (Kadoch and
Crabtree, 2015)
Histone PTMs are also known to aid cellular differentiation by regulating gene expression
(Giadrossi et al., 2007b). During pluripotency the levels of the silencing mark, H3K9me3, are barely
delectable (Saraiva et al., 2010). On the contrary, cells show high levels of the activating marks
H3K27ac and H3K4me3. As cells differentiate to neurons the levels of the repressive mark
H3K27me3 increase as well as H3K4me3 creating bivalent domains. (Podobinska et al., 2017).
Through development, the deposition of H3K27me3 by the PRC2 complex regulate stem cell
plasticity (Margueron and Reinberg, 2011). In differentiated cells for example, H3K27me3 has been
shown to silence pluripotency related genes (Luis et al., 2012), while in pluripotent ESCs, PRC2
deposits H3K27me3 on developmental related genes (Richly et al., 2011).
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Another key regulator of ESCs differentiation is DNA methylation, in fact, loss of DNA
methylation has been shown to increase embryo apoptosis (Giadrossi et al., 2007b). During
development, DNA methylation regulates several processes such as X chromosome inactivation,
imprinting and telomere length (Podobinska et al., 2017). During development, DNA methylation
occurs in several waves (Smith and Meissner, 2013). In mammalian cells, germlines are highly
methylated. After fertilization, there is a wave of demethylation that lasts until the blastocyte stage.
Afterwards, DNA methyltransferase enzymes (DNMTs) drive the first wave of methylation until the
epiblast stage (Greenberg and Bourc’his, 2019).

1.4 Mass spectrometry as a tool to interrogate chromatin biology
When studying histone PTMs to interrogate chromatin biology, mass spectrometry (MS) based
approaches are the method of choice. Due to its high reproducibility and high throughput, MS has
emerged as the optimal method when detecting and quantifying histone PTMs (Baker, 2012).
Compared to antibody-based methods such as western blotting, MS has the ability to identify novel
PTMs using unbiased approaches. Additionally, researchers can quantify over 100 PTMs in a
single MS run (Sidoli et al., 2012). To date, there are three MS approaches to analyze histone
PTMs; (1) bottom-up MS, where histones are digested to short peptides (4-10aa), (2) Middle-down
MS, here histone tails are digested to longer peptides (50aa) and (3) Top-Down MS, where full
length histones are analyzed without enzymatic digestion (Karch et al., 2013).

Bottom-up MS is the traditional approach in most proteomics experiments (figure 1.6).
Compared to middle-down and top-down MS, bottom up requires just a few micrograms of starting
material and can be performed using low resolution MS (Guo et al., 2018). Using this methodology,
proteins are digested to small peptides (4-10aa) using trypsin, which cleaves after lysine (K) and
arginine residues (R). Following trypsin digestion, peptides are separated by high performance
liquid chromatography (HPLC) based on hydrophobicity.
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More specifically, C18 columns are used as stationary phase whereas the liquid phase is
composed by an aqueous and an organic solvent (Sidoli et al., 2016). While this approach is easily
done in proteomics experiments, histones are more challenging. As histones are rich in K and R
residues, enzymatic digestion with trypsin will result in short peptides that are too hydrophilic for
C18-based chromatography. Additionally, such peptides do not contain enough charge density for
MS analysis. To circumvent this, the Hunt lab developed a chemical derivatization method that
increases the peptide hydrophobicity and produce longer peptides after trypsin digestions. This
method utilizes propionic anhydride to chemically modified primary amines (protein N terminus,
unmodified, mono, and di methylated lysine residues) (Garcia et al., 2007). After derivatization,
trypsin digestion only cleaves after R, resulting in longer peptides (4-10aa). Furthermore, a second
round of derivatization is done to the newly generated N-termini, with the resulting peptides mostly
+2 and +3, making them ideal for collision induced dissociation (CID) or higher-energy collision
dissociation (HCD) in the mass analyzer.

Derivatization (K)

Digestion

Derivatization
(N-term)

LC-MS

Figure 1.7 General schematic of histone bottom-up MS analysis. Prior trypsin digestion, lysine
resides are derivatized (shown in orange), in the second step histones are digested with trypsin
and a second round of derivatization is done to the newly generated N-terminus. Samples are
desalted (not shown) and analyzed by LC-MS.

Histone PTMs do not occur in isolation and the co-existence of two or more PTMs have
been shown to play key roles in chromatin regulation. The notion of histone PTMs crosstalk
establishes that one modification can promote the generation of another mark (Figure 1.7)
(Suganuma and Workman, 2008).
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In yeast H3S10ph is known to promote acetylation of H3K14ac (Walter et al., 2008). This
short distance crosstalk can be easily identified using the traditional bottom-up MS approach,
however most PTM crosstalk occurs in long distance PTMs (H3K4-H3K14), which cannot be
inferred with bottom-up MS. Middle-down MS has the advantage of retaining a longer peptide
sequence, making it easier to study long range PTMs. In this type of analysis, histones are digested
with GluC protease to generate longer peptides (50-60aa), corresponding to the N-terminal tails of
histones where the majority of PTMs are located. In this approach, histone tails are resolved using
weak-cation exchange chromatography based on hydrophilic interactions (WXC-HILIC) using a
saltless pH gradient (Lu et al., 2020). Once in the mass spectrometer, histone tails are fragmented
using electron transfer dissociation (ETD) (Sidoli et al., 2014) or ultraviolet photodissociation
(UVPD)(Greer et al., 2018)

me

me

ac

me

H3 N-A R T K Q T A R K S T G G K A P...G V K K...-C
4

9

14

36

Figure 1.8 Illustration of histone PTM crosstalk in H3. Red line indicates negative crosstalk
while blue lines show possible crosstalk between 2 PTMs. Me represent methylation (shown in light
blue) and ac represent acetylation (shown in green). Figure adapted from (Latham and Dent,
2007).

A less common MS method to analyze histone PTMs is Top-Down proteomics where the
intact histone proteins are analyzed without enzymatic digestion. This method requires more
starting material and can only be done in high resolution instruments. (Karch et al., 2013). In topdown MS,

histones are directly infused to the mass spectrometer and analyzed without

chromatographic separation (Toby et al., 2016). However, some studies have opted to fractionate
the histone prior MS analysis thus lowering the sample complexity (Anderson et al., 2016). Similar
to middle-down analysis, in top-down experiments, histones are fragmented in the mass analyzer
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using electron transfer dissociation (ETD) (Karch et al., 2016) or ultraviolet photodissociation
(UVPD) (Greer and Brodbelt, 2018).

Beyond the analysis of histone PTMs, mass spectrometry-based proteomics also offer a
unique platform to study nucleosome dynamics. Hydrogen deuterium exchange coupled to MS
(HDX-MS) has been widely used to analyze protein stability in solution. Protein conformation and
stability determines the exchange rate of deuterium with amide hydrogens in the polypeptide
backbone, with more stable secondary structures being protected from exchange compared to less
stable structures (Hamuro et al., 2003). Therefore, the rate of deuterium exchange is a proxy for
stability. HDX-MS allows the measurement of changes in protein stability and localizes these
differences to specific regions (Chalmers et al., 2011; Kan et al., 2013), HDX-MS has been used
to map the binding interface of H2A/H2B dimer with its chaperon NAP1 (D’Arcy et al., 2013).
Furthermore, the Black group, employed HDX-MS to analyze how the histone H3 variant, CENPC, stabilizes nucleosomes (Falk et al., 2015). Additionally, HDX-MS has been combined with both
middle-down and top-down MS to characterize structural fluctuations of the histone tails during
nucleosome formation (Karch et al., 2018). This study showed for the first time how histone tails
gain more rigidity after being incorporated into nucleosomes.

Taken together, these studies highlight the broader capability of MS approaches in
chromatin biology, from histone PTM identification and quantitation, to PTM crosstalk, and histone
dynamics. Through my dissertation I utilized MS-based proteomics and different genomics
approaches to understand how histone H2A proteolysis regulates cellular differentiation. My
findings show that H2A is cleaved by the lysosomal protease Cathepsin L during ESCs
differentiation. Using quantitative MS, I demonstrated that L23 is the primary cleavage site that
gives rise to the clipped form of H2A (cH2A), which reaches a maximum level of ~1% of total H2A
after 4 days of differentiation. Furthermore, I utilized chromatin immunoprecipitation followed by
next generation sequencing (ChIP-seq) and found that preventing proteolysis leads to an increase
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in acetylated H2A at promoter regions in differentiated ES cells. Altogether, my finding suggest that
proteolysis serves as an efficient mechanism to silence pluripotency genes and destabilize the
nucleosome core particle (chapter 2).

The third chapter of this dissertation will focus on my efforts to optimize the current middledown platform introducing an easy and user-friendly guide to perform and evaluate histone middledown experiments. Here, I demonstrate that the utilization of porous graphitic carbon (PGC) resin
during the desalting step reduced sample loss. I also tested different salts in the WCX-HILIC buffers
for their effect on retention, selectivity, and reproducibility of analysis of variants of histone tail
fragments. I found that replacing ammonium ion with ethylenediammonium ion in the mobile phase
results in more reproducibility and increase the number of H3 isoforms identified. These results
provide a streamlined way to evaluate middle-down performance to identify and quantify
combinatorial histone PTMs.
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CHAPTER 2: Cleavage of histone H2A during embryonic stem cell differentiation
destabilizes nucleosomes to counteract gene activation.
2.1 Introduction
Eukaryotic cells condense their DNA into chromatin through the formation of nucleosomes
consisting of two copies of histone H3-H4 tetramers and two copies of histone H2A-H2B dimers
wrapped around approximately 150bp of DNA (Strahl and Allis, 2000).Within the nucleosome,
histone tails (1-30) are the major acceptors of post translational modifications, with the most
common being acetylation, methylation and phosphorylation. Histone PTMs such as acetylation,
methylation and phosphorylation have been extensively studied and correlated with gene activation
(H3K27ac), gene silencing (H3K9me3) or mitotic checkpoints (H3S10ph) (Chen et al., 2018).
Histone PTMs are vital for gene expression during cellular development and cell fate determination.
Embryonic stem cell differentiation gives rise to the three germ layers, endoderm,
mesoderm and ectoderm, which is critical for development (Keller, 2005). This process of
differentiation is tightly regulated by external signaling as well as internal factors including
transcription factors and epigenetic modulators, which have been shown to remodel chromatin
during cell fate commitment (Mas et al., 2018). In fact, during cell lineage commitment, cells
experience major changes in chromatin arrangement, resulting in alterations of gene expression
(Dixon et al., 2015; Giadrossi et al., 2007). Undifferentiated cells have open and accessible
chromatin, but as the cells differentiate the chromatin becomes more compact and displays less
physical elasticity (Atlasi and Stunnenberg, 2017). These changes are the results of physical
alterations driven by chromatin remodelers acting to reposition nucleosomes and/or promote
histone variant exchange (Biran and Meshorer, 2012). Covalent modifications such as methylation,
acetylation and phosphorylation on histone tails, regulated by histone modifiers enzymes, act to
signal the state of a region of chromatin (Giadrossi et al., 2007). For instance, during the early
stages of differentiation, ES cells show high levels of acetylation, a mark of active chromatin, while
the heterochromatic mark histone 3 lysine 9 trimethylation (H3K9me3) is barely detectable in
pluripotent ES cells (Saraiva et al., 2010).
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Histone proteolysis, on the other hand, is a less explored and more drastic PTM in which
the histone tails are enzymatically cleaved, thereby eliminating the possibility of future PTMs until
histone exchange occurs. Histone proteolysis has been observed in different biological contexts.
H2A, for example, has also been shown to undergo proteolysis in acute monocytic leukemia at
residue V114. (Glibert et al., 2014). Similarly, H2B has been found to be cleaved in hepatocytes
(Tvardovskiy et al., 2015). Histone clipping appears to be regulated not only through the primary
amino acid sequence but also through the PTMs on histone tails. JMJD5 and JMJD7 have been
shown to cleave methylated arginine in mouse embryonic fibroblasts (MEFs) (Liu et al., 2017).
Furthermore, during osteoclastogenesis, H3K18ac has been shown to modulate proteolysis of H3
by matrix metalloproteinase 9 (MMP-9) (Kim et al., 2016).

In the context of cellular development, the lysosomal protease Cathepsin L (CTSL) has
been shown to cleave H3 during ESC differentiation (Duncan et al., 2008). Cathepsin L localizes
to the nucleus upon Ras activation, where it is known to cleave the CDP/Cux transcription factor to
regulate the cell cycle (Goulet et al., 2004). Additionally, Cathepsin L has been shown to promote
cellular senescence in IMR90 fibroblasts and primary melanocytes by cleaving the histone variant
H3.3 (Duarte et al., 2014). CTSL knockout embryos exhibit abnormal visceral endoderm formation
(Tholen et al., 2014). Furthermore, CTSL-deficient mice show irregular hair follicle development
and other skin pathologies (Tobin et al., 2002). The biological significance of histone proteolysis
by CTSL in regulating gene expression during stem cell differentiation remains unresolved as well
as if it clips other histones and the consequence of histone cleavage in nucleosome stability are
yet to be investigated.
Here, we report that Cathepsin L cleaves histone H2A during embryonic stem cell
differentiation. We hypothesize H2A proteolysis serve as efficient mechanism to remove acetyl
sites on nucleosomes by cleavage of the tail, thus counteracting gene activation during
development. Using high-resolution quantitative mass-spectrometry (qMS) we quantified and
localized the primary cleavage sites to lie between amino acids 22-25. Additionally, we found that
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Cathepsin L knockdown leads to a global increase of H2A acetylation after four days of
differentiation. Using chromatin immunoprecipitation followed by next generation sequencing
(ChIP-seq) we found acetylated H2A is redistributed to promoter regions upon Cathepsin L
knockdown. We have also discovered that members of the SWI/SNF protein complex bind
acetylated H2A but are not able to interact with cleaved H2A (cH2A). Lastly, we found that cH2A
containing nucleosomes and dimers are less stable than full length H2A (FL-H2A), as revealed by
protein degradation analysis. Taken together our data not only uncover cellular consequences of
histone proteolysis, but also describes the role this cleavage has in altering H2A modifications and
nucleosome stability during cell fate commitment.

2.2 Results
2.2.1 The N-terminal tail of histone H2A is cleaved during mouse embryonic stem cell
differentiation
Prior studies have reported that histone H3 is cleaved upon cellular differentiation (Duncan
et al., 2008). To determine if differentiation involves the cleavage of other histones, we treated
mESCs with retinoic acid (RA) to induce their differentiation into embryoid bodies (EBs) as our
model system (Figure 2.1 A). Using immunoblot analysis, we identified that histone H2A is cleaved
upon differentiation at day one and four (Figure 2.1 B) and no change was observed for H2B. Next,
we sought to interrogate whether cH2A still associates with chromatin by isolating mononucleosomes from undifferentiated mESCs and EBs using micrococcal nuclease (MNase)
digestion. As shown in Figure 2.1C, cH2A is only present in mono-nucleosomes derived from EBs,
but not in undifferentiated cells (consistent with our results in Fig. 2.1B). This further suggests that
cH2A is chromatin-bound in EB.

Next, we utilized mass spectrometry to identify the cleavage site in H2A and to quantify the
levels of cH2A upon differentiation. Histones from differentiated and undifferentiated mESCs were
extracted with acid and then further purified by reverse phase liquid chromatography (RP-HPLC).
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Characteristic fractions corresponding to canonical H2A.1(Lin and Garcia, 2012) (Supplementary
Fig. 2.1A) were analyzed by liquid chromatography coupled to MS (LC-MS). In agreement with our
immunoblot data, we detected cleavage of H2A at day 2 of differentiation, which significantly
increased after four days of RA treatment. The most abundant cleavage site was L23 with ~1% of
all H2A being cleaved at this site (Figure 2.1, D and E). Other cleavage sites that increased through
differentiation were identified at F25, V27 and G37. Though additional cleavage sites were detected
along the H2A tail (Supplementary Fig 2.1B-D), their abundance did not change during
differentiation, indicating that these sites were not regulated during cell development.

Numerous variants of H2A exist, including MacroH2A, H2A.Z, and H2A.X, which have
distinct roles in cellular differentiation (Nashun et al., 2010). Although addressing whether H2A
variants undergo cleavage during development is beyond the scope of this work, sequence
alignment shows that the cleavage motif is conserved across the majority of the variants
(Supplementary Fig 2.1E). However, It remains to be determined if these variants are being cleaved
during differentiation or other biological processes.
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Figure 2.1. Histone H2A is cleaved during ES cells differentiation. A Undifferentiated ES cells, the
second panel illustrated embryoid bodies formation after Retinoic acid (RA) treatment. B Western
blot analysis on acid extracted histone or C mononucleosmes during 6 or 5 days of differentiation,
arrow indicates the presence of cleaved H2A (cH2A). D Mass Spectrometry quantification of cH2A.
Asterisk indicate significant differences between undifferentiated (day 0) and differentiated cells
(day 2 and 4), two-tail student t-test (*p < 0.05, **p < 0.01) and least 3 biological replicates in each
time point. E Illustration of the N terminal tail of H2A, dotted lines indicate secondary cleavage sites
while solid line denotes primary and most abundant proteolytic site.
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2.2.2 Cathepsin L facilitates H2A proteolysis upon cellular differentiation

Previously, we reported that cathepsin L (CTSL) cleaves H2A in vitro (Anderson et al.,
2016) and other studies have similarly found CTSL-mediated cleavage of histones using in vitro
reconstituted nucleosomes (Papanastasiou et al., 2019). Analysis of the cleavage sites of cathepsin
L substrates revealed a motif containing glutamine residues at the P1 position and aromatic
residues in the P2 position (Biniossek et al., 2011). Cathepsin L cleaves H3 at Q/LAT (/ indicates
cleavage site) (Duncan et al., 2008), this motif is similar to where H2A is being cleaved (G/LQF)
(Figure 2.2A). Together, this led us to the hypothesis that cathepsin L serves as the H2A protease.

To interrogate this, we expressed control shRNA (shSC) or shRNA against CTSL (shCTSL)
in mESCs (Figure 2.2B). We next differentiated mESCs with RA for two days and analyzed acidextracted histones by immunoblot. Although shCTSL mESCs still differentiated into embryoid
bodies, cleavage of H2A was reduced compared to the control (Figure 2.2C). Similarly, when we
blotted for total H3, we also found less cleavage of histone H3 (cH3) in shCTSL cells compared to
control cells (Figure 2.2C). To quantify the levels of cH2A upon cathepsin L knockdown, we
employed top-down MS to monitor intact H2A as well as the cleavage products. Here, again we
quantified a significant reduction of cH2A upon cathepsin L knockdown (Figure 2.2D and
Supplementary Figure 2.2 A and B). Proteolysis was observed not only at L23 but also at other
residues, including V27, suggesting that CTSL may have more than one cleavage site on H2A.
However, the abundance of L23 was three-fold higher than V27, indicating that L23 is most likely
the primary cleavage site for cathepsin L in vivo (Figure 2.2D).
To understand how cleavage of H2A by CTSL affects post-translational modification (PTM)
patterns, we analyzed acetylation levels at H2AK5 and H2AK9, as these marks are associated with
gene activation (Wang et al., 2008). Our mass spectrometry data shows that the acetylation levels
of H2AK5 and H2AK9 changes during normal mESC differentiation. In undifferentiated cells, the

31

levels of all possible forms of acetylated H2A (K5ac, K9ac and dually acetylated K5acK9ac) are
approximately 10% (Supplementary Figure 2.2 C-E). Two days after RA treatment these levels
increase significantly to 19%. Finally, after 4 days of RA treatment, acetylation levels decrease to
7%. To interrogate how CTSL proteolysis affects the levels of acetylated H2A during differentiation
(Figure 2.2E), we quantified the levels of acetylated H2A in control and shCTSL cells after RA
treatment. Here, we spiked in synthetic peptides corresponding to H2AK5ac, H2AK9ac,
H2AK5acK9ac and the unmodified H2A peptide. As shown in Figure 2F, the levels of H2AK5ac,
significantly decreased after 4 days of RA treatment in control but not shCTSL cells. In fact, the
levels of H2AK5ac were relatively unchanged. Similarly, H2AK9ac levels did not decrease in
shCTSL cells. Although at day two the levels of H2AK9ac and the dually acetylated peptide seems
lower in mESC shCTSL cells, the trend still holds, where at day four acetylation levels were not
decreased. Together, our data indicates that Cathepsin L-mediated proteolysis serves to rapidly
remove multiple acetyl marks on the H2A N-terminus, thereby regulating gene expression during
differentiation.
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Figure 2.2. Cathepsin L facilitates H2A proteolysis upon differentiation. A Sequence similarity
between H3 and H2A cleavage sites. B Knockdown validation of Cathepsin L in undifferentiated
and differentiated cells, GAPDH was used as loading control. C Western blots on acid extracted
histones from undifferentiated WT mESCs and differentiated embryoid bodies WT and CTSL KD
D Mass Spectrometry quantification of cH2A after 4 days of RA treatment. Asterisk indicate
significant differences between scramble shRNA (shSC) or CTSL KD cells (shCTSL), two-tail
student t-test (*p < 0.05) and least 3 biological replicates in each time point. E Illustration of the
post translational modifications on the N-terminal tail of histone H2A. F MS quantification of histone
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acetylation marks on H2A on differentiated ES cells. two-tail student t-test (*p < 0.05, **p < 0.01)
and N=3.

2.2.3 Knockdown of CTSL leads to genome wide redistribution of acetylated H2A in stem
cells

To

look

at

H2A

acetylation

localization

genome

wide,

we

used

chromatin

immunoprecipitation followed by next generation sequencing (ChIP-Seq) of H2AK9ac in shSC and
shCTSL mESCs across three differentiation timepoints to determine where H2AK9ac resides in the
genome. Given that histone tails, specifically those of H3 and H4, have been shown to be
dynamically modified during stem cell differentiation (Gonzales-Cope et al., 2016) and our
observations indicating that H2A is also dynamically acetylated during differentiation, we asked
how proteolysis regulated the genome wide localization of H2A acetylation. Here we performed
ChIP-seq for H2AK9ac in control and CTSL KD mESCs before and after differentiation into
embryoid bodies (Figure 2.3A). Alterations in the total levels or genomic distribution of H2AK9ac in
undifferentiated CTSL KD cells compared to control cells were not apparent by MS or ChIP-seq
(Supplementary figure 2.3A-B). In agreement with our MS data, we found a genome wide decrease
in H2AK9ac from Day 2 to Day 4 of EB formation in WT mESC cells (Figure 2.3B and
supplementary figure 2.3C). We also observed a reduction of H2AK9ac at Day 2 but not Day 4
when cathepsin L was knocked down. Moreover, differential binding analysis showed ~1.2% of
peaks change significantly between day 2 and day 4 in the control (Log2 fold change >1 (up) < -1
(down) FDR < 0.05), which was not observed upon knockdown of CTSL (Supplementary figure
2.3D). Interestingly, gene ontology analysis showed that genes with significantly less H2AK9ac at
day 4 are involved in cellular differentiation and nervous system development (Supplementary
figure 2.3E).
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When we compared the enrichment profile of H2AK9ac after four days of EB formation, we
found that the shCTSL cells have overall higher levels of acetylation across gene bodies (Figure
2.3C). When determining the genomic distribution of H2AK9ac, we found a 4% increase at
promoters in shCTSL EBs (Supplementary figure 2.3F). We next examined the expression levels
of genes marked with H2AK9ac at their promoter. We clustered promoters into three groups:
promoters with H2AK9ac in both WT and CTSL KD and those found exclusively in WT or shCTSL
cells. Our data shows that the expression of genes with H2AK9ac peaks exclusively in shCTSL
cells is lower than those with peaks exclusively in control cells, suggesting that CTSL-induced
proteolysis could promote gene silencing (Figure 2.3D). One of the genes found to gain H2AK9ac
at its promoter upon KD of Cathepsin L was Pou5f1, a known regulator of stem cell pluripotency.
As shown in Figure 2.3E, after four days of EB formation, the signal of H2AK9ac on the promoter
decreases dramatically (blue), but upon Cathepsin L KD, the signal of H2AK9ac on the Pou5f1
promoter increased. Taken together this data suggest that H2A proteolysis by Cathepsin L aids in
gene regulation by silencing genes involve in pluripotency while activating genes to promote cell
linage commitment. One of the genes found to gain H2AK9ac in its promoter upon KD of cathepsin
L was Pou5f1, a known regulator of stem cell pluripotency. As shown in Figure 2.3E, at Day 4 of
EB formation, the signal of H2AK9ac on the promoter decreases dramatically (blue), but upon
cathepsin L KD, the signal of H2AK9ac on the Pou5f1 promoter increased. Taken together, these
data suggest that H2A proteolysis by cathepsin L aids in gene regulation by silencing genes involve
in pluripotency while activating genes to promote cell linage commitment.
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Figure 2.3. Genome wide localization of acetylated H2A A Schematic of differentiation time points
used for ChIP-seq and RNA-seq analysis. B Heatmap showing enrichment of H2AK9ac over
H2AK9ac consensus peaks (n=11,050) at day 2 and day 4 of EBs formation in control cells (shSC)
or CTSL KD cells (shCTSL). C Profile plots of H2AK9ac after 4 days of RA-induced differentiation.
D Box plot showing gene expression by RNA seq of promoters that are shared between SC and
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CTSL KD (yellow), and promoters uniquely found in SC (blue) or CTSL KD (orange). P< 2.2 x 106
(share vs KD) Wilcoxon-rank sum two-sided was used to determined significance. E Genome
browser representation of colocalization of H2AK9ac over the promoter of Pou5f1 in KD cells after
4 days of RA treatment. shSC tracks are colored in blues while shCTSL are in oranges, with
exception of day 0, all sequencing experiments were done at least twice.

2.2.4 Acetylated H2A is recognized by the PBAF complex in mESCs

Changes in the H2A acetylation patterns upon loss of CTSL expression likely alters the
recruitment of chromatin regulatory proteins. In addition to H2AK9Ac, our MS data showed
increased H2AK5ac in differentiated cells upon CTSL KD, a mark associated with gene activation
(Vavouri and Lehner, 2012; Wang et al., 2008) but readers of this mark remain to be identified. To
determine binding partners of H2AK9ac and H2AK5ac as well as the dual acetylated H2A
(H2AK5acK9ac), we used synthetic peptides for H2AK5ac, H2AK9ac and H2AK5acK9ac and we
performed peptide pulldown assays. Isolated proteins were characterized by LC-MS/MS with
further validation of hits by immunoblot (Figure 2.4A). Histone H2A is known to be N-terminally
acetylated to near 100%(Tweedie-Cullen et al., 2012). Recent studies have shown that as H2A
emerged from the ribosome, following N-terminal methionine cleavage, the N-terminal
acetyltransferase NatD recognizes the first 4 amino acids on H2A and acetylates the new Nterminal Serine residue (Magin et al., 2015). Therefore, as a negative control we used H2A peptide
containing N terminal acetylation.

As shown in Figure 2.4B and C, H2AK5ac and H2AK9ac peptide baits were able to pull
down members of the Polybromo-1 BRG1 Associating Factor (PBAF) chromatin remodeler
complex more so than unmodified H2A peptide. STRING analysis on the enriched proteins, showed
that dually acetylated H2A was able to pull down PBAF members such as Smarcd1 Phf10, Pbrm1
and Brd7. The enrichment of these proteins was more prominent when H2A was acetylated at K5
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and K9 simultaneously (Figure 2.4D, supplementary Fig 2.4A). Histone H4 is also known to be
acetylated within in its N-terminal tail, which is similar in sequence to H2A and may therefore also
interact with the PBAF complex. Repeating our affinity pulldown experiments using unmodified and
dually acetylated (K5acK8ac) H4 peptides, we also observed enrichment of PBAF by the
H4K5acK8ac peptide. As expected, the main reader for H4K5acK8ac, Brd4, (Gonzales-Cope et
al., 2016; Miller et al., 2016) attained greater enrichment than Brg1 and Brd7 (supplementary Figure
4B-C). PBRM1 has been previously reported to bind H3K14ac (Porter and Dykhuizen, 2017), which
we likewise observed in our experiments. However, we found that Pbrm1 also has affinity for
H2AK5acK9ac (Figure 2.4F). Similarly, Brd7 preferentially binds to dually acetylated H2A
compared to other histone peptides, although it appears to have a higher affinity to H2AK5ac when
tested alone in vitro (Supplementary Figure 2.4B), suggesting that additional proteins may enhance
recognition of dually acetylated H2A. We also found that Brg1 showed similar affinity for all
acetylated peptides (Fig 2.4D and Supplementary Fig. 2.4A) and that TBP binds acetylated H2A
and H4, highlighting its positive correlation with gene activation (Supplementary Figure 2.4D).
A
Undifferentiated
mESCs

Nuclear extracts

Pulldowns
LC-MS

C

15

10

BRD7

15

10

Pnn

Pnn

5

ZSC10

PBRM1

B

B

B

0

0
-4

-2

FC H2AK5ac/H2A

F

PHF10
PBRM1

5

BRD7

150-

Input (3%)

Protein complex enriched in H2AK5acK9ac
SMARCB1

2

4

H3K14ac

E

10

H2A unmodified

D

0

FC H2AK9ac/H2A

H3 unmodified

4

H4 unmodified

2

H4K5acK8ac

0

H2AK9ac

-2

H2AK5acK9ac

-4

-log2 p-value

BRD7

5

HP1B

H2AK5ac

B

-log2 p-value

B

75-

BRD7

250-

BRG1

100-

0
-5

-3

0

3

5

250-

FC H2AK5acK9ac/H2A

150-

38

PBRM1

Figure 2.4 Members of PBAF recognized acetylated H2A. A Representation of histone peptide
pulldown experiments using nuclear extracts. Volcano plots showing the fold change between
unacetylated H2A (control) peptide and (B) H2AK5ac, (C) H2AK9ac or (D) H2AK5acK9ac.
Significantly enriched proteins over control peptide are labeled in blue (student t-test). E String
analysis showing interconnection between proteins that were found to be enriched in
H2AK5acK9ac pulldown. F Western blots validation of MS results.

2.2.5 H2A proteolysis prevents PBAF recognition of acetylated H2A

Since the modifications on histone N-terminal tails can regulate the recruitment of proteins
to chromatin, proteolytic severing of the tails could preclude interactions normally mediated by
modifications on the tails. We hypothesized that removal of the H2A tail, and therefore H2A tail
acetylation, would disrupt binding of PBAF to H2A. To test this, we performed coimmunoprecipitation followed by MS (IP-MS) analysis using mESCs expressing either FLAGtagged full-length H2A (FL-H2A) or N-terminally truncated H2A, representing cleavage at L23
(cH2A). Inspection of the interactome of FL-H2A compared to cH2A revealed that 96% of the
proteins interacted with both cH2A and FL H2A (Figure 2.5A). Similar to our peptide pulldown
studies, members of the SWI/SNF chromatin remodeler complex (Smarcd1 and Actl6a) were only
found to interact with FL-H2A and not cH2A. Additionally, we found that Importin-9 (Ipo9) was
enriched two-fold for cH2A over FL-H2A (Figure 2.5B and C). IPO9 is known to translocate H2AH2B dimers from the cytosol to the cell nucleus (Padavannil et al.). We also found that Npl1
(nucleosome assembly protein 1, also known as Nap1), which is known to exchange H2A/H2B
dimers (Chen et al., 2016), was enriched by cH2A over FL-H2A. Surprisingly, we found Cbx1, 3
and 5 to interacts preferentially with FL-H2A (Figure 2.5B and C). Gene ontology analysis showed
that the proteins enriched by cH2A are typically associated with RNA splicing and gene expression,
while those enriched with FL-H2A are involved in nucleosome assembly and DNA packaging
(Supplementary Fig. 2.5A-B).
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We next validated our IP-MS results by doing co-immunoprecipitation assays followed by
immunoblotting. As shown in Figure 2.5D and Supplementary Figure 2.5C, FL-H2A co-precipitated
with Pbrm1 more so than cH2A. Additionally, Pbrm1 but not Smarcc2 (BAF170) co-precipitated
with FL-H2A, suggesting that PBRM1 interacts with H2A acetylation through its six tandem acetyllysine binding bromodomains, which bind to acetylated lysine residues. Taken together, these
results indicate that the PBAF protein complex recognizes acetylated H2A and that H2A proteolysis
abrogates this recognition (Figure 2.5E).

Figure 2.5 H2A proteolysis prevents PBAF recognition of acetylated H2A A Ven diagrams showing
overlapping and unique proteins identified by IP-MS. B . Volcano plots showing the fold change
between FL-H2A (blue) and cH2A (orange) Significantly enriched proteins student t-test are
highlighted in blue or orange. C Bar plot of proteins differentially enriched in each condition, student
t-test ;*p < 0.05, **p < 0.01, ***p < 0.0001. D Co-IPs using whole cell extracts of mESCs expressing
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either FLAG-tagged full-length H2A (FL-H2A) or FLAG-tagged cH2A (cH2A). E Recognition of
acetylated H2A by the PBAF before and after histone proteolysis.

2.2.6 cH2A is associated with marks of active transcription and fast turnover

Our IP-MS results found a reduced interaction between Cbx proteins and cH2A compared
to FL H2A. Cbx1, also known as heterochromatin protein 1b, plays an important role in gene
silencing through its interaction with methylated lysine 9 on histone H3 (H3K9me) (Kaustov et al.,
2011). This raised the possibility that nucleosomes enriched with cH2A are depleted of histone
H3K9me marks. To examine this possibility, we purified mono-nucleosomes containing cH2A and
analyzed their PTMs by MS (Supplementary Fig 2.6A). As expected, nucleosomes with cH2A were
mostly depleted of mono-, di- and tri-methylation at H3K9 compared to those with FL-H2A (Figure
2.6A,B). Instead, we found that cH2A-containing nucleosomes had higher levels of histone marks
associated with gene expression, such as H3K14ac and H3K36me3 (Figure 2.6A). Taken together,
this data suggests that cH2A is associated with accessible chromatin, likely due to its precursor,
H2A, being hyperacetylated.

Interestingly, we found that cH2A preferentially interacts with Npl1, a protein known to
exchange H2A/H2B dimers. Thus, we hypothesized that cH2A-containing nucleosomes are readily
exchanged or evicted compared to FL-H2A-containing nucleosomes. Additionally, loss of the Nterminal tail of H2A likely disrupts DNA-histone interactions that play important roles in the
maintenance of nucleosome structure. Indeed, during cellular processes such as replication and
transcription, the nucleosome undergoes conformational changes to allow access to DNA.
Moreover, histone tail proteolysis has been shown to destabilize the nucleosome in vitro (Nurse et
al., 2013). Our recent publication using hydrogen deuterium exchange coupled with mass
spectrometry (HDX-MS), showed that in a nucleosome context, the N-terminal tail of H2A is
protected from exchange (Karch et al., 2018). Aside from affecting histone modifications, cleavage
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of H2A by cathepsin L could also affect nucleosome structure and stability. To measure the stability
of cH2A in cells, we blocked protein synthesis with cycloheximide. We found that while FL-H2A
protein levels remain stable for at least eight hours, cH2A undergoes rapid degradation (Figure
2.6C). Notably, in our IP-MS experiment, we found that cH2A but not FL-H2A interacted with
Trim21(Figure 2.5A), a ubiquitin ligase known to target proteins for proteasomal degradation (Clift
et al., 2018). To investigate whether cH2A was being degraded by the proteasome, cells were
treated with the proteasome inhibitor bortezomib and cH2A stability was subsequently monitored
for eight hours. As shown in Figure 2.6D, the levels of cH2A still decrease after bortezomib
treatment. This was further confirmed by treating cells simultaneously with cycloheximide and
bortezomib (Figure 2.6E), indicating that cH2A may be degraded by another pathway. Overall, our
data suggest that histone proteolysis occurs in open chromatin to remove key PTM sites and disrupt
binding interactions, thus facilitating nucleosome eviction and gene silencing of pluripotency genes.
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Figure 2.6. cH2A is associated with marks of active transcription and fast turnover.
Mononucleosome IP-MS quantification of histone PTMs enriched in FL-H2A A or cH2A.
significance is denoted by asterisk (*). Student t-test ;*p < 0.05, **p < 0.01, ***p < 0.0001. B MS
validations by western blot. Protein chase assay using C cycloheximide 100ng/ml D or bortezomib
(10nM) or both D. Western blots against FLAG or H3 in nuclear extracts. All experiments were
done in biological triplicates

2.3 Discussion

Histone proteins undergo a wide variety of changes to their PTM patterns to regulate gene
expression. On one hand, the addition of a chemical moiety, predominantly on lysine and arginine
residues are known to compact or loosen the chromatin environment or recruit proteins to affect
transcription. On the other hand, chromatin remodeler complexes exert physical force to evict or
slide nucleosomes along the DNA to orchestrate gene expression. While most of these processes
are widely understood, histone proteolysis is not. The first report of histone clipping dates occurred
three decades ago (Allis et al., 1980), where histone H1 was found to be cleaved in Tetrahymena
micronuclei. Since then, different studies have also described histone proteolysis in organisms such
as sea urchin (Morín et al., 2012), chicken (Mandal et al., 2012), and yeast (Santos-Rosa et al.,
2009). These studies contribute to the idea that histone proteolysis represents a mechanism of
gene regulation similar to canonical histone PTMs. Indeed, Duarte et al. found that histone H3
proteolysis during cellular senescence promotes gene silencing of cell cycle related genes

In the context of cellular development, cathepsin L has been shown to cleave histone H3
(Duncan et al., 2008), but the downstream effects have remained unclear. Complementing this
study, we now report that histone H2A is also cleaved by cathepsin L during embryonic stem cell
differentiation. Using high resolution mass spectrometry, we demonstrated that H2A undergoes
proteolysis at amino acid L23, accounting for almost 1% of the entire H2A population in
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differentiated cells (Figure 2.1D). Although we found other proteolytic events in undifferentiated
cells, they were not responsive to cathepsin L knockdown, which suggests the possibility of other
H2A proteases beyond cathepsin L. In addition to cleavage at L23, we also found a secondary
cleavage site at V27, which is significantly reduced upon cathepsin L knockdown (Figure 2.2D).
This was not surprising given that in histone H3, cathepsin L is known to target a primary site (A21)
as well as secondary sites. One hypothesis is that cathepsin L first cleaves at L23, located right
before the alpha 1-helix, and then proceeds to cleave again at V27 (contained in the alpha one
helix), leading to further nucleosome destabilization by weakening DNA-histone interactions.

In vitro studies have found that cathepsin L is more active when H3 is acetylated at H3K18ac.
However, dual acetylation at K18 and K23 has the opposite effect (Duncan et al., 2008). Given that
histone H2A is also highly acetylated within its N-terminal tail, we sought to interrogate how
proteolysis affects H2A acetylation in vivo. We anticipated that changes in acetylation due to
proteolysis would be difficult to monitor due to the stoichiometry being only 1%. Therefore, instead
of using our standard histone PTM analysis platform (Karch et al., 2016), we designed a more
sensitive method to monitor levels of H2A acetylation using synthetic internal standards and
multiple reaction monitoring (MRM) MS. Here we found the levels of acetylated H2A to increased
upon CTSL KD.
It is important to reiterate that the overall abundance of H2AK5ac is roughly 8% in
undifferentiated cells, which doubles two days after RA exposure. By day 4, the level of this mark
decreases to ~9%. A similar trend is observed with H2AK9ac, which increases from 1% in
undifferentiated cells to 2% in early differentiation before decreasing back to 1% in late
differentiation. Since these observations are at the global level, localizing these changes more
precisely in the genome may aid in uncovering how H2A acetylation regulates gene expression
during cellular development. Furthermore, investigating how proteolysis affects genome-wide
distribution of acetylated H2A will elucidate how this novel process contributes to cell fate decisions.
We hypothesized that genes regulated by H2A proteolysis would retain H2A acetylation after four
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days of RA treatment in cells with knockdown of CTSL. We performed ChIP-seq in control and
cathepsin L KD mESCs. Surprisingly we found a redistribution in the genomic localization of
H2AK9ac. After four days of RA treatment, the proportion of H2AK9ac peaks in promoter regions
increased by 4% (Figure 2.3F). Examining the expression of genes having promoter proximal
H2AK9ac peaks only present in KD cells, we found generally lower levels of expression than genes
with promoter proximal H2AK9ac peaks only present in control cells. This suggests that proteolysis
promotes gene silencing as expected. As shown in Figure 2.3F, we found increased levels of
H2AK9ac on the Pouf5f1 gene, a well-known positive regulator of pluripotency. In line with the
findings from Duarte et al., we proposed that proteolysis serves as a rapid mechanism to silence
genes involved in pluripotency, allowing cells to proceed through differentiation.

Our data indicates that H2A acetylation plays a key role in driving gene expression during
development. Prior studies have found that H2A acetylation is associated with gene activation in
Drosophila (Doiguchi et al., 2016). Acetylation on H2AK5ac and H2AK9ac is known to be deposited
by Tip60 (KAT5) (Jacquet et al., 2016). In ESCs, Tip60 is known to activate genes involved in
proliferation and cell renewal (Acharya et al., 2017). While the role of this acetyltransferase has
been extensively described, little is known about H2A acetylation in ESCs and the readers of this
mark. Our data showed that members of the PBAF SWI/SNF chromatin remodeler complex
recognized different forms of acetylated H2A and had higher affinity for the dual mark,
H2AK5acK9ac (Figure 2.4). As shown in Figure 2.4, PBAF members also seem to bind to
H4K5acK8ac. This can be explained by the sequence similarity on the N-terminal tails of H4 and
H2A. Consistent with prior findings, we confirmed that BRD4 is the main reader of H4K5acK8ac.
As previously reported, we also observed H3K14ac to interact with Brd7 and Pbrm1. A possible
explanation is that H3K14ac and acetylated H2A co-exist in the same nucleosome or in
hyperacetylated chromatin regions. We also cannot exclude the additional possibility that Pbrm1
could accommodate all acetyl sites given its six tandem bromodomains.
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The PBAF complex has been shown to play a key role in maintaining pluripotency (Hiramatsu
et al., 2017). In addition to H3K14ac (Porter and Dykhuizen, 2017), members of this the BAF family
are known to also interact with H3K4me1 (A et al., 2017). Given that PBAF also recognizes
acetylated H2A, we propose that this interaction is diminished upon H2A proteolysis. Indeed,
utilizing immuno-affinity precipitation followed by MS (IP-MS) and validation by immunoblotting, we
found that FL-H2A but not cH2A is able to interact with the PBAF complex. Additionally, we also
found that CBX proteins interact preferentially with FL-H2A over cH2A. Interactions between CBX
proteins and FL-H2A could be mediated through the association of FL-H2A with H3K9 methylation.
As demonstrated in Figure 2.6, FL-H2A-containing nucleosomes show enrichment for H3K9
methylation. Conversely, cH2A nucleosomes were found to be more associated with active marks,
such as H3K9ac and H3K14ac, suggesting that histone proteolysis occurs in euchromatic regions.
Finally, we also found that cH2A destabilizes nucleosomes in vivo (Figure 2.6), suggesting that
proteolysis may promote nucleosome eviction.
Taken together, our studies uncover a novel mechanism of gene regulation during cell fate
determination. We propose a model in which cathepsin L mediates the proteolysis of H2A to
remove acetylation on the N-terminal tail, thereby silencing genes involved in the maintenance of
pluripotency. This silencing is accomplished by preventing the recruitment of PBAF to acetylated
H2A, which abrogates chromatin remodeling at these genes and blocks the binding of
transcriptional machinery.
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Figure 2.7. Prosed model of gene regulation by H2A proteolysis.

2.4 Materials and methods

2.4.1Cell Culture
CCE-Nanog-GFP MESCs were a donated by Ihor Lemischka. Cells were grown at 37°C in
5% CO2 using DMEM with high glucose and sodium pyruvate(Thermo), and was supplemented
with 15% characterized FBS (Hyclone,), non-essential amino acids (MEM) (Thermo), Glutamax
(Thermo), 10µm 2-mercaptoethanol(Thermo) and LIF(Millipore). Cells were grown 0.1% gelatin
(Millipore) coated plates and GFP sorted by flow cytometry before downstream experiments. For
embryoid bodies formation, ~1.5X107 cells were plated in 10-cm petri dishes in media without LIF
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and supplemented with 10µm all-trans retinoic acid (Sigma). Cells were kept with constant rotation
for 4 days and media was changed every other day. All cell lines were tested for mycoplasma. To
generate CTSL KD and Flag-tagged H2A (FL and cH2A) mESCs, approximately 4X105 HEK293T
cells were transfected with 2 packaging vectors pPAX2 and VSGV (kind gift from Dr. Shelley
Berger) along with 1µg of shRNA targeting CTSL, FL-H2A or cH2A was included. shRNA plasmid
for CTSL KD was obtained from the high throughput core at Penn and scramble control was a gift
from Dr. Shelly Berger. To generate FLAG-Tagged FL-H2A and cH2A, DNA fragments were cloned
into pLenti plasmid (Origene) (EcoRI and PSPXI) both constructs were C-terminus FLAG-tagged.
HEK293T were transfected in mESCs media (without LIF) and virus particles were collected for 3
days. Prior to transduction, the virus was filtered using 0.45µm and polybrene (Santa Cruz
Biotechnology) was added to a final concentration of 8ug/ml. Cells were infected for 24 hours
followed by selection with 1µg/ml of puromycin (Thermo) for 5 days. Transduction efficiency of FLH2A and cH2A was validated by immunoblotting with FLAG antibody (Sigma). The knockdown
efficiency was confirmed by RT-qPCR and immunoblots, in both cases GAPDH was used as a
loading control. To asses protein stability, mESCs expressing FL-H2A and cH2A were treated with
cycloheximide (Sigma) (100µg/mL), Bortezomib (Sigma)(10nM) or a combination of both drugs for
eight hours, and timepoints were collected every two hours. Cell pellets were snap frozen in liquid
nitrogen and store at -800C.

2.4.2 Histone isolation and nuclear extraction
Histones were isolated as previously described (Lin and Garcia, 2012). In summary, after
nuclei isolation, histones were acid extracted with H2SO4 for three hours, following by precipitation
with trichloroacetic acid (TCA) overnight. The resulting pellets were washed first with acetone
containing 0.1% of hydrochloric acid (HCL) followed by a wash in acetone alone. Finally, samples
were resuspended in ultrapure water and protein concentrations were estimated by Bradford assay
(BioRad). To generate nuclear extracts, ~1 X106 cells, were lysed in hypotonic buffer (10mM Tris
pH 8, 2mM MgCl2, 24mM CaCL2, 0.3M sucrose, 0.5% NP-40 and protease inhibitors) for five
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minutes on ice. The nuclei were pelleted at 500g for five minutes and washed with PBS. Nuclear
proteins were released on ice for 30 minutes in nuclear extraction buffer (10mM HEPES pH 7.9,
0.75mM MgCL2, 500mM NaCl, 0.1mM EDTA, 12.5% glycerol) supplemented with Benzonase
2.5U/ul (Millipore) and protease inhibitors (Bimake).
Antibodies
All antibodies used in this study are listed in Supplementary Table 1.
2.4.3 Co-immunoprecipitation (Co-Ips) and protein Identification by Mass Spectrometry
Co-Ips were performed as previously described ( (Lin-Shiao et al., 2018). Briefly, 2X107
cells were lyse for 1hr at 40 C in IP buffer (20mM Tris pH 7.5, 137mM NaCl, 1mM CaCl2, 1% NP40, 10% glycerol, 1mM MgCl2 and 12U/ml Benzonase) supplemented with protease inhibitors
(Bimake). Antibodies (FLAG, BAF180, BAF170, IgG) were conjugated to 30µl protein G magnetic
beads (Thermo) in blocking solution (0.5% BSA in PBS) for at least 2hrs at 4°C. cell lysate (~600µg)
were added to the conjugated antibody and incubated overnight at 4°C. IP samples were washed
three times with IP buffer and eluted in SDS loading buffer for immunoblots or processed for MS
analysis by on-beads digestion (FL-H2A and cH2A Ips). Before trypsin digestion, beads were
resuspended in 50mM NH4HCO3, reduction, alkylation and digestions were done as mentioned
above. Resulting peptides were dried by SpeedVac centrifugation and store at -80°C. After stage
tipping, samples were resuspended in MS buffer A (0.1% formic acid in MS grade water) and
analyzed by LC-MS. Samples were loaded onto a 17-cm in house C18 column (Reprosil-Pur) using
a Dionex LC (Thermo Scientific) coupled to a QE-HF orbitrap mass spectrometer (Thermo
Scientific). Peptides were eluted over 90-minute gradient from 5-35% solvent B (A- 0.1%FA, B80% acetonitrile, 0.1% FA), the flow rate was set to 300nl/min. Data was obtained in data
dependent mode (DDA), the MS1 was acquired over 300-1200 m/z with a resolution of 60,000,
AGC target of 5e5, and maximum injection time of 100 ms. For the MS2, the top 25 most intense
ions were selected for MS/MS by high-energy collision dissociation (HCD) at 27 NCE, with a
resolution of 30,000, AGC target of 1e5, and maximum injection time of 150 ms. Raw files were
processed using MaxQuant (v 1.6.0.16) (Cox and Mann, 2008) using M. Musculus database
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(Uniprot, April 2017). For MS/MS database search the precursor mass tolerance was set to 4.5ppm
and the product mass tolerance to 0.5 Da. Two trypsin missed cleavages were allowed,
carbamidomethyl (C) was set as static modification, oxidation (M) as well as acetyl (protein N-term)
were selected as variable modifications. Proteins were quantified using label-free quantification
(iBAQ), and finally, protein false discovery rate (FDR) were filtered for < 0.01.

2.4.4 Mononucleosme IP and histone PTMs ID by MS
Cells were lysed in Buffer A (10mM HEPES pH 7.9, 10mM KCL, 1.5mM MgCl2, 0.34M
Sucrose, 10% glycerol 1mM DTT, 0.1% Triton-X and protease inhibitors) on ice for 5min, after
centrifugation, pellets were washed with Buffer A without Triton-X. Soluble nuclear proteins were
released for 15 on ice in no salt buffer (3mM EDTA, 0.2mM EGTA, 0.1mM DTT). Mononucleosomes
were obtain by digesting the chromatin in 30 units of Micrococcal nuclease (Mnase)(Roche) in
digestion buffer (50mM HEPES, 2mM CaCL2 0.2% NP-40) for 10min at 37 °C. Chromatin was
briefly sonicated at 20% amplitude. Sample was further clarified by centrifugation and DNA was
examined by agarose gel. Monucleosomes were dialyzed against Buffer D (20mM HEPES pH 7.9,
20% glycerol, 0.2mM EDTA 0.2% Triton X, and protease inhibitors) for 2hr at 4°C. Following
dialysis, ~100ug of mononucleosomes were incubated with FLAG-M2 beads (20µl) overnight at
4°C. After three washes with Buffer D (+100mM NACL), samples were eluted with 3X FLAG peptide
(0.33mg/ml) on ice for 45min and analyze by immunoblotting and MS. For MS analysis, samples
were run on a SDS gel and bands around 25-10kDa were cut out. Histone peptides were derivatized
as described in Sidoli and Garcia 2017 (Sidoli and Garcia, 2017). In summary, after two rounds of
in gel derivatization, samples were digested with 12.5ng/µl of trypsin (Promega) overnight. Peptides
were eluted form the gel after several iteration of hydration with NH4HCO3 and dehydration with
acetonitrile. Samples were dry by SpeedVac centrifugation and resuspended in 50mM NH4HCO3
for two more rounds of derivatization. As described above, peptides were analyzed by LC-MS.
Here, peptides were eluted over a 60-minute gradient from 5-35% solvent B (A-0.1% FA, B-80%
acetonitrile, 0.1% FA), the flow rate was set to 300nl/min. Data was obtained in data independent
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mode (DIA). The MS1 was done in high resolution (120, 000) using 300-1,100m/z windows, for
MS2, 16 DIA events of 50m/z were acquired using HCD (NCE =35). Raw files were processed
using EpiProfile (Yuan et al., 2018). These experiments were performed in triplicate.

2.4.5 Peptide pulldowns and protein identification by MS
Histone peptide pulldown assays were done as previously described by Vermeulen
(Vermeulen, 2012) with minor modifications. In brief, nuclear extracts were prepared by lysing
mESC in buffer A (10mM HEPES pH 7.9, 1.5mM MgCl2, 10mM KCL) supplemented with protease
inhibitors. Cells were incubated on ice for 10min and pelleted at 400xg for 5mins. Subsequently,
cell pellets were further homogenized in buffer A supplemented with 0.15% NP-40 and protease
inhibitors. The nuclei were pelleted after spinning at 3200xg for 15min, nuclear proteins were
released for 1hr at 4°C in Buffer C (420mM NaCl, 20mM HEPES pH 7.9, 20% glycerol, 2mM MgCl2,
0.1% NP-40 and protease inhibitors). Protein concentration was estimated by Bradford assay.
Synthetic peptides were purchased from GenScript. Peptides were designed to include
H2AK5ac, H2AK9ac, H2AK5acK9ac, H3K14ac and H4K5acK8ac, as well as control peptides, and
all peptides were biotinylated at the C terminus. The exact sequences of the peptides are listed in
Supplementary Table 2. Each peptide (~25ug) was congregated with 75µl of Dynabeads MyOne
C1 (ThermoFisher) for 20 minutes at room temperature in peptide binding buffer (150mM NaCl,
50mM Tris pH 8, 0.15 %NP-40). Nuclear lysate was diluted to 0.6µg/ml in protein binding buffer
(150mM NaCl, 50mM Tris pH 8, 0.15NP-40, 0.5mM DTT, 10uM ZnCl2 and protease inhibitors).
Nuclear lysates (~500ug) were incubated with conjugated peptides overnight at 4C. After 5 washes
with protein binding (350mM NaCl) samples were eluted with SDS loading dye for MS or
immunoblot analysis. For MS analysis, samples were run in 4-12% SDS page (NuPage). Gel was
cut from 250-10kDa and divided into 4 different fractions. Before trypsin digestions, proteins were
reduced with 5mM DTT for 45min at 55°C and alkylate with 55mM iodoacetamide at room
temperature for 30min. Samples were digested overnight, and peptides were eluted as previously
mentioned. Proteins were identified by MS as described in the Co-Ips section.
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2.4.6 H2A Top-down analysis by LC-MS
Prior to mass spectrometry analysis, individual histones were fractionated by reversedphase liquid chromatography (RP-HPLC) as previously described (Greer et al., 2018). Briefly,
~200µg of purified histones were fractionated using Vydac C18 column. Samples were eluted using
a 100min linear gradient (30-60%B). Solvent A consisted of 5% acetonitrile (ACN) in HPLC-grade
water and .2% trifluoracetic acid (TFA), where Buffer B was 95% ACN and .2% TFA. Fractions
corresponding to H2A.1 were collected based on known retention time and characteristic peaks
(Supplementary Fig 1 A). Samples were then dried using a SpeedVac and store at -80 °C. Fractions
corresponding to H2A.1 were resuspended in 0.1% Formic acid (FA) to a final concentration of
1µg/µl. Samples (2µg ) were loaded onto a 75-um (inner diameter) x 20 -cm C18 column (ReprosilPur Germany) and injected into a nano Liquid Chromatography (nLC). Proteoforms were eluted
over 60min using a non-linear gradient (10-40B%). Solvent A consisted of 0.1% Formic acid while
buffer B was 80% acetonitrile (ACN). nLC was coupled to a hybrid Orbitrap Fusion Mass
Spectrometer equipped with electron transfer dissociation (ETD) fragmentation (Themo). The
acquisition was done in data dependent mode with top speed with 3 second cycle time and using
high resolution of MS1 (120,000 at 200=m/z) and tandem MS2 (30,000). For MS1 and MS2 the
AGC target was set to 2.0E5 with an injection time of 100ms for MS1 and 300 for MS2. Charge
state 5-21 were selected for MS2 fragmentation with ETD, finally 3 micro scans were average to
yield high resolution MS/MS spectra. Data analysis was performed as described in Sidoli et.al with
minor modifications. (Sidoli et al., 2017). In brief, after spectra deconvolution with Xtract (Thermo),
files were search with Mascot (v2.5 Matrix Science) Dynamic modifications such as acetylation (K)
and methylation (KR) were included, no enzyme was selected for digestion. Results files were
further process using IsoScale (Sidoli et al., 2017) and filtering for unambiguous identification, all
cleavage sites were normalized to the abundance of the full length H2A, manually extracted using
Xcalibur (Thermo Fisher Scientific)
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2.4.7 Quantitative Proteomics with Multiple Reaction Monitoring (MRM) of H2A acetylation
For histone UHPLC-MRM-MS analysis, 20µg of histone were derivatized as previously
described (Karch et al., 2016). After two rounds of derivatization, samples were digested with
trypsin overnight. Tryptic peptides were derivatized again for two more rounds and peptides were
desalted by stage tipping (Karch et al., 2016). The multiple reaction monitoring (MRM) method was
developed on a Vanquish liquid chromatography system and TSQ Altis triple quadrupole mass
spectrometer (Thermo Scientific) to quantify H2A tail acetylation. Using heavy labeled AQUA
standard peptides, targets were scheduled with using a 15min gradient, peptides were loaded onto
a Accucore 1.5µm, 15cm C18 column (Thermo Scientific) heated to 60°C at a flow rate of 300µl/min.
Using aqueous solution of 0.1% formic acid as Buffer A and organic solution of 80% acetonitrile
0.1% formic acid as Buffer B, the gradient began at 5% Buffer B and increased to 50% Buffer B by
13.9min, then increased to 95% Buffer B at 15.0min where it remained for 2 minutes, and finally
decreased to 5% Buffer A at 17.1min where it remained for 6 minutes. Peptides were introduced
into the mass spectrometer by H-ESI source in positive mode at 3700V, sheath gas of 25Arb,
auxiliary gas of 4Arb, sweep gas of 1Arb, ion transfer tube temperature of 325°C, and vaporizer
temperature of 350°C. A final method was created using the previous parameters coupled to
multiple reaction monitoring with a total number of 164 transitions, dwell time of 2.5ms, Q1
resolution of 0.4 Da, Q3 resolution of 0.7 Da, and at least ten points across each peak were
quantified. Data analysis where the heavy to light ratio of each peptide to standard was carried out
in Skyline (MacLean et al., 2010). All experiments were done in triplicate.

2.4.8 Chromatin Immunoprecipitation followed by sequencing (ChIP-seq)
ChIP-seq was done as previously reported (Lin-Shiao et al., 2018) . Briefly, 1X107 mESCs
were fixed in 1% formaldehyde in PBS for 10 minutes, the fixation was quenched with 125mm
glycine for 5 minutes. Chromatin was sonicated with a S220 Focused-ultrasonicator (Covaris) for
15 min and immunoprecipitated with H2AK9ac (Abcam). Antibodies were conjugated to protein G
Dynabeads (Thermo). Eluted samples were reverse cross-linked overnight at 65°C, and DNA as
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purified after treatment with RNAse (Thermo) and Proteinase K (Thermo). Purified DNA was
quantified using Qubit dsDNA kit (Thermo) and 50ng was used to prepare sequencing libraries.
Input samples were also included and prepared using the same protocol. NEBNext Ultra DNA
library kit from Illumina (New England Biolabs) was used to prepare the libraries and the quality
was assessed by Agilent BioAnalyzer 2100 (Agilent). Quantification was done using KAPA library
quantification kits (KAPA Biosystems) or NEBNext library Quant kit (New England Biolabs). For
each condition, two independent replicates were included. Single-end sequencing (75bp) was
performed on a NextSeq 500 platform. (Illumina). Reads were check for sequencing quality with
FastQC (v0.11.2). After that, reads were aligned to the mouse reference genome (mm9) using
Bowtie2 (v2.2.9) with soft-clipping allowed. SAMtools (v0.1.19) was used to filter out non-primary
alignments, alignments with mapping quality score less than 10, PCR duplicates, alignments on
non-chromosome contigs and on ENCODE blacklist regions. Peaks were detected for each sample
against the corresponding input control using SICER (v1.1) with default parameters. Bedtools
(v2.27.1) was used to generate bedgraph files for visualization on genome browser, in which each
sample was normalized to 10 million reads per library and corresponding input subtracted.

2.4.9 Whole transcriptome analysis by RNA-seq

RNA was extracted utilizing RNAeasy Kit (Qiagen) following manufacturer’s instructions.
Treatment with DNAse for 15 minutes was included to degrade all genomic DNA. Libraries were
prepared using NEBNext Poly(A) mRNA magnetic isolation module and NEB Ultra Directional RNA
Library kit for Illumina (New England Biolabs). Libraries quality, quantification and, sequencing was
done as described above. RNA-seq reads were check for sequencing quality with FastQC
(v0.11.2). After sequencing, reads were aligned to the mouse reference genome (mm9) using
STAR (v.2.3.0e) with default parameters. SAMtools (v0.1.19) was used to filter out alignments with
mapping quality score less than 10 and alignments on mitochondria or non-chromosome contigs.
Finally, FeatureCounts (v.1.6.2) was used to generate a matrix of mapped fragments per RefSeq
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annotated gene. Differential gene expression analysis was performed using the DESeq2 R
package (v.1.16.1) with an FDR cutoff of 0.05 and log2 fold change cutoff of 1.5X. Bedtools
(v2.27.1) was used to generate bedgraph files for visualization on genome browser, in which each
sample was normalized to 10 million reads per library.
GO analysis
All gene ontologies analysis were done using GENEONTOLOGY at http://geneontology.org/
2.4.10 Data availability
Mass spectrometry raw files are deposited in the Chorus (https://chorusproject.org/) project ID
1698. Additionally, all ChIP and RNA seq files are in the NCBI Gene Expression Omnibus under
the following accession number GSE162896
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2.6 Supplementary figures

Supplementary figure 2.1. A Representative chromatogram of Reverse-phase fractionation (RPHPLC) of acid extracted histones from mESCs. Top-down quantification of proteolytical events
found in day 0 (in proportion 0.01 =1%) B, 2-C and 4-D. Error bars represent standard deviation of
3 experiments. E Sequence alignment of H2A variants, yellow box showed sequence homology
on the most abundant cleavage site of H2A after 4 days of differentiation.
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Supplementary figure 2.2 . Top-down quantification of proteolytical events in shSC (control) and
shCTSL mESCs in undifferentiated A and after 2 days of differentiation B. Only peptides found in
2 out of 3 replicates are reported. Bottom-up quantification of H2AK5ac C, H2K9ac D and
H2AK5acK9ac E during ES differentiation (n=3). Error bars represent standard deviation of 3
experiments.
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Supplementary figure 2.3. A MS quantification of H2AK9ac in undifferentiated ES cells shSC
(blue) or shCTSL KD (orange) using synthetic peptides as standards. Error bars represent standard
deviation of 3 experiments. B Genomic features of H2AK9ac in undifferentiated cells SC (blue)
and CTSL KD (orange). ChIP seq of undifferentiated cells was done once. C Heatmap of H2AK9ac
chip signal over mm10 genes. D DiffBind(Stark and Brown) analysis comparing Day 2 vs day 4 in
SC control or CTSL KD. E Gene ontology of differentially downregulated genes from day 2 to day
4 of EBs formation in SC control. F Genomic localization of H2AK9ac in day 4 of EBs formation in
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Supplementary figure 2.4. A Peptide pull-down using unmodified H2A, H2AK5ac, H2AK9ac or
H2K5acK9ac peptides. Pull-downs were carryout using nuclear extracts of undifferentiated,
western blots were done against proteins that showed >2-fold enrichment by MS. B in-vitro peptide
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pull-down using recombinant BRD4 or recombinant BRD7. C Peptide pull-down of H4 and
H4K5acK8ac, western blot against BRG1 and BRD4, well-known reader of acetylated H4. D
Peptide pull-down using unmodified H2A, H2K5ac, K9ac, H2K5acK9ac, H3, H3K14ac, H4 and
H4K5acK8ac peptides. Western blots were done against Oct4 (negative control) and TBP.
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Supplementary figure 2.5. Gene ontology of proteins found to interact with cH2A A or FL-H2A B
with FC > 0.5 and p-value > 0.05 using unpaired t-tests. Top 10 categories are showed. C
Biological replicate of CO-Ips in figure 5 D.
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Supplementary figure 2.6.

A Simplified schematic of monoucleosme IP procedure. B

Biochemical fractionation showing cH2A is chromatin associated. C Biological replicates of protein
stability experiments described in figure 6 C and D.

2.7 Supplementary tables
Supplementary table 1. Antibodies used in this study
Target

Source

Concentration/Application

FLAG

Sigma F3165

3ug (Ip), 1:5000 WB

BAF180

Millipore ABE70

5ug (Ip), 1:1000 WB

BAF170

Active motif 61471 (IP)

5ug (Ip)

BAF170

Cell signaling (WB)

1:1000 WB

ARID2

Thermo Invitrogen pa5-5128

1:1000 WB

BRG1

Abcam 110641

1:1000 WB

BRD7

Cell signaling 15125s

1:1000 WB

TBP

Abcam 133239

1:1000 WB

OCT4

Abacam 19857

1:1000 WB

H2AK9ac

Abcam 177312

3ug ChIP

H2A-acidic patch

Millipore 07-146

1:1000 WB

Cathepsin L

R&D biosystems AF1515

1:1000 WB

GAPDH

Cell signaling

1:10000 WB

BRD4

Abcam 128874

1:1000 WB

GST

Cell signaling 2622s

1:1000 WB

H3

Abcam 1791

1:5000 WB

H2B

Cell Signaling

1:1000 WB

IgG

Abcam 171870

5ug (Ip)
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Supplementary table 2. Synthetic peptides used in this study (20aa)
Histone

Peptide sequence

Name

Ac-SGRGKQGGKARAKA{Lys(Biotin)}TRSSR

H2A unmodified

Ac-SGRG{Lys-Ac}QGGKARAKA{Lys(Biotin)}TRSSR

H2K5ac

Ac-SGRGKQGG{Lys-Ac}ARAKA{Lys(Biotin)}TRSSR

H2AK9ac

Ac-SGRG{Lys-Ac}QGG{Lys-

H2AK5acK9ac

H2A

Ac}ARAKA{Lys(Biotin)}TRSSR

H4

Ac-SGRGKGGKGLGKGGAKRHR{Lys(Biotin)}

H4 unmodified

Ac-SGRG{Lys-

H4K5acK8ac

Ac}GG{LysAc}GLGKGGAKRHR{Lys(Biotin)}

H3

ARTKQTARKSTGGKAPR{Lys(Biotin)}QL

H3 unmodified

ARTKQTARKSTGG{Lys-Ac}APR{Lys(Biotin)}QL

H3K14ac
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CHAPTER 3: Bullet points to evaluate the performance of the middle-down proteomics
workflow for histone modification analysis
3.1 Introduction
Mass spectrometry (MS) is one of the most commonly used approach to identify and
quantify histone post-translational modifications (PTMs). Given its high mass accuracy and
versatility, quantification of over 200 modified species can easily be achieved in one hour with
commonly used online liquid chromatography - MS (LC-MS). In the shotgun approach, or bottomup MS, histones are propionylated and digested with trypsin, typically generating peptides of
between 4-20 amino acids. A second round of propionylation is then needed to derivatize the newly
generated N-termini (Karch et al., 2013; Sidoli et al., 2016). Bottom-up MS is the most common
workflow for histone PTMs identification and quantification. It can be performed with low-resolution
instruments using collision induced dissociation (CID) (Karch et al., 2014) or higher energy
collisional dissociation (HCD) (Figure 3.1). In triple quadrupole mass spectrometers, for example,
the data is acquired using multiple reaction monitoring (SRM) where transition peptides of a known
mass are used for quantification (Darwanto et al., 2010; Zheng et al., 2016a). Histone peptides
have unique challenges for MS detection due to the presence of isobaric or “nearly” isobaric forms.
For instance, acetylation on lysine residues generates a mass shift of 42.01 Da, while a
trimethylation 42.04 Da; this mass difference can be distinguished either by very high resolution
(>60,000) or retention time shift (acetylation is more hydrophobic). In the case of completely
isobaric forms, the most commonly used approach is quantifying the intensity of MS2 fragment ions
(Marczak et al., 2016; Zheng et al., 2016a) Interestingly, differential ion mobility has shown
promising results as well, in particular with longer polypeptide sequences (Yuan et al., 2015). MS2
acquisition to discriminate isobaric forms should be performed in a way that the entire elution profile
contains MS2 data points; a single MS2 could be misleading, if the two isobaric forms do not
completely co-elute. MS2 can be then performed either using targeted methods (SRM or targeted
product ion scan) or with windows-based data independent acquisition (DIA) (Marczak et al., 2016),
where large isolation windows are used to fragment all signals independently of the ions present in
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the MS1 event (Janssen et al., 2017). Since ions are being selected for fragmentation at each duty
cycle, MS2-based extracted ion chromatograms are more accurate, making the experiment
feasible even with low-resolution mass analyzers such as ion traps (Sidoli et al., 2015).
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Figure 3.1. Current workflows to analyze histone post-translational modifications.
In bottom-up analysis (top arrow) after trypsin digestion, samples are analyzed using reversedphase chromatography (RPC). As for fragmentation type in bottom-up studies, collision-induced
dissociation (CID) is typically used. In the middle arrow, middle-down strategy is presented, wherein
samples are digested using GluC instead of trypsin. Histone tails are further separated using WCXHILIC and fragmented for identification using electron transfer dissociation (ETD) or ultraviolet
photodissociation (UVPD). The top-down approach is represented by the bottom arrow. Typically,
histones are purified using reverse-phase liquid chromatography. For top-down analysis, RPC or
WCX-HILIC is used. The fragmentation is done similarly to middle-down.

For studies of PTMs distant from each other in the sequence, top-down and middle-down
approaches are needed. In top-down MS, histones are analyzed without digestion, utilizing
electron-transfer dissociation (ETD) and more recently ultraviolet photodissociation (UVPD) (Greer
and Brodbelt, 2018). This method greatly benefits from separating individual histone classes using
reversed-phase chromatography (RP-HPLC) prior to MS injection to reduce the complexity of the
spectra. In some cases, an additional fractionation step is needed before MS analysis (Wang et al.,

73

2018). After fractionation, individual histones are analyzed by LC-MS either using weak cation
exchange chromatography (Tian et al., 2012; Tvardovskiy et al., 2015), C18-based chromatography,
or directly infusing the sample into the mass spectrometer (Zheng et al., 2016b). In top-down MS
for histone analysis, data is acquired using data dependent acquisition (DDA) and only charges +9
or higher are selected for fragmentation (Molden and Garcia, 2014). Although the entire histone
can be analyzed using top-down MS, this approach still has several limitations. First, the up-front
requirement of sample fractionation is not only time-consuming but requires large amounts of
starting material (usually hundreds of micrograms of purified histones). Moreover, chromatography
is very limited in separating intact histones, leading to very complex mixed MS2 spectra containing
isobaric forms, nearly-isobaric forms (acetylated vs trimethylated peptides) and even histone
variants due to their sequence homology (Önder et al., 2015). A few laboratories have developed
methods to deconvolute the complexity of those spectra e.g. (Dang et al., 2016; Pesavento et al.,
2006), but both identification and quantification still remain challenging.

Middle-down MS strategy has become the method of choice to study combinatorial histone
PTMs. In this workflow, histones are most frequently digested with the protease GluC, producing
N-terminal peptides (“tails”) 50-60 residues long that can be further analyzed by LC-MS. In middledown experiments, histone tails are often separated using weak cation exchange columns in the
hydrophilic interaction chromatography mode (WCX-HILIC). Since histone tails are highly charged
molecules, typical fragmentation (HCD or CID) strategies do not produce enough fragment ions to
allow precise localization of PTMs. For this reason, Electron Transfer Dissociation (ETD) is the gold
standard for histone middle-down analysis, with UVPD emerging as a potential alternative (Greer
et al., 2018). Middle-down analysis can be combined with metabolic labeling to answer questions
regarding catalysis rates of PTM formation (Sidoli et al., 2017). With this method, it is possible to
quantify the coexistence frequency of two or more PTMs, and investigate the likelihood of two or
more modifications being on the same tail using normalization methods like the interplay score
(Schwämmle et al., 2014, 2016). Over the past few years, middle-down MS analysis has grown in
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popularity, yet it is still limited in reproducibility and robustness compared to bottom-up (Sidoli and
Garcia, 2017a). Moreover, data analysis and instrument setup do not have well-defined
benchmarks, creating communication barriers when defining satisfactory vs. unsatisfactory
performance. We present a detailed protocol to perform middle-down MS of hypermodified histone
tails, focusing on tips and benchmarks on how to evaluate adequacy of performance of this
workflow.
3.2 Results

3.2.1 Utilization of porous graphitic carbon (PGC) in the desalting step

Middle-down MS generates histone peptides spanning the entire N-terminal tail, which is
important in quantifying combinatorial modifications along the tail. As the histone tails generated
have high hydrophilicity and basicity (due to the basic groups from lysine and arginine residues),
WCX-HILIC is commonly used in separating the different modified forms (Young et al., 2009).
Peptides are retained both through electrostatic attraction and hydrophilic interaction. A decreasing
gradient of ACN tunes down the hydrophilic interaction (Jensen et al., 2013) while a decreasing pH
gradient uncharges the polyaspartic acid-coated PolyCAT A stationary phase, tuning down the
electrostatic attraction. The eluting peptides are then directly introduced via nanoelectrospray
ionization into the mass spectrometer equipped with electron transfer dissociation (ETD)
fragmentation. Using ETD for MS2 fragmentation is highly efficient for highly charged intermediatelength histone peptides, resulting in high sequence and PTM coverage (Cristobal et al., 2017; Good
et al., 2007).

We demonstrate that adding porous graphitic carbon (PGC) (Bapiro et al., 2016; West et
al., 2010) on top of the C18 plug helps reduce sample loss during the desalting process, as it has
higher capacity and more efficient binding for polar molecules than C18 material (Figure 3.2A). A
significantly larger number of identified H3 combinatorial modifications were identified in samples
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desalted using Stage tips containing PGC as bulk resin, suggesting that PGC complements the
retention from C18 material. In summary, identification and quantification of about 200 histone
codes from histone H3 is considered a good performance. Importantly, the washing step prior to
the elution should be performed with MS grade water without acids to avoid acidifying the sample
in the elution buffer.
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Figure 3.2. StageTip comparison to assess sample loss prior to MS/MS analysis. (A) Number of
identified proteoforms from histone samples desalted via RPC StageTip with or without additional
PGC resin. A total of 3 replicate runs were performed. * Indicates two-tailed t-test with a p-value <
0.05. (B) Pearson correlation of proteoforms identified from the different StageTip runs; BU
denotes histone samples analyzed by bottom-up proteomics. The two middle-down runs have the
higher correlation, but when compared to bottom-up analysis, PGC + C18 stage tips showed
higher correlation than C18 only. Additionally, PGC + C18 also shows lower coefficient of variation
(CV) values (C).
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3.2.2 Re-evaluation of WCX mobile phase

In WCX-HILIC chromatography of histones, buffer A usually consists of 75% acetonitrile
with 20mM (overall) propionic acid pH 6 adjusted with ammonium hydroxide (NH4OH), while buffer
B is 25% acetonitrile at pH 2.5, adjusted with formic acid (Young et al., 2009). One of the biggest
challenges in middle-down proteomics is the reproducibility of the chromatography and tedious
work in buffer preparation. Moreover, laboratories often do not have a dedicated LC system just for
middle-down analysis. With this in mind, we recommend using 0.1% formic acid (FA) as buffer B,
which is frequently buffer A in C18-based chromatography. This minimizes time in buffer preparation
and changes in LC configuration. For buffer A, we now recommend adjusting the pH using
ethylenediamine (EDA) instead of NH4OH. Compared to ammonium ion, ethylenediammonium ion
is a better-hydrated anion (Cohen et al., 2012) and forms better-hydrated ion pairs with the acidic
residues in histones (Alpert, 2018). As a result, the peptides are better retained in the HILIC mode,
and the selectivity for acidic residues increases relative to that of the numerous basic residues.
This results in the interesting change in selectivity seen in Figure 3.3A. More variant sequences
are identified as well (Figure 3.3B). The use of EDA instead of NH4OH also results in more
reproducible quantification as measured from the coefficient of variation (Figure 3.3C).
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Figure 3.3. Evaluation of middle-down chromatography. (A) Chromatogram showing separation of
different acetylation variants. In the top panel, the buffer contained EDA while NH4OH was used in
the bottom panel. (B) Number of proteoforms identified using different bases to adjust the pH of
buffer A. (C) Violin plots representing the distribution of CV for each condition (three replicate runs).

3.2.4 Determining proper fragmentation
Proper fragmentation is key to assign PTMs unambiguously. After data acquisition, the
fragmentation efficiency can be determined by looking at the MS2 spectra in Mascot. Fragment ion
coverage is key for proper assignment of PTMs. An example of ETD fragmentation showing
sufficient (A) and insufficient (B) MS/MS ion coverage is shown in Figure 3.4. Electron transfer
without dissociation (“ET no D”) will result in insufficient fragmentation. In this case, at the MS2
level, the parent ion is the most abundant species, followed by the reduced charged precursor
(Figure 3.4C). In this case we recommend (1) verifying the intensity of the fluoranthene reagent in
the mass spectrometer, making sure that it is higher than 5E6; (2) using angiotensin reagent to
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make sure that the instrument is performing optimally, and; (3) calibrating the ETD parameters and
making sure that negative electron multipliers are calibrated.
A

Sufficient

B
Insufficient
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Figure 3.4. Evaluation of ETD fragmentation.
Representative MS2 spectra showing sufficient (A) vs insufficient (B) fragmentation. Figure C
shows electron transfer with no dissociation, a common problem when using ETD fragmentation.
3.2.4 Data visualization and interpretation

After data processing, middle-down experiments usually yield at least 150 IDs. As shown
in Figure 3.5A, most peptides have 2 or 3 PTM modifications. As shown in Figure 3.5B, over 100
co-existence frequencies for binary PTMs were identified in this study, indicating high quality data.
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Figure 3.5. Assessing data quality. (A) Number of peptides containing multiple PTM modifications
on the same tail. (B) Frequency of binary PTMs identified with the combinations listed. Over 100
coexisting binary PTMs should be obtained in a successful middle-down experiment.
To visualize co-existing PTMs and their frequencies, we generated a ring plot using the
interplay score as shown in Figure 3.6A. The interplay score was calculated using the relative
abundance of a given binary modification (ab) using the following equation:
𝐼𝑛𝑡𝑒𝑟𝑝𝑙𝑎𝑦!" = 𝑙𝑜𝑔#

𝐹!"
𝐹! ∗ 𝐹"

Here, Fab is the observed abundance of the binary modification and Fa*Fb is the predicted
frequency of a given combinatorial modification, which is a function of the abundance of each
individual PTM (Schwämmle et al., 2014; Sidoli and Garcia, 2017b). Histone modifications that are
never found on the same tail do not have a calculated interplay value. If two PTMs are mutually
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exclusive, then the interplay score will be negative, while positively related modifications will yield
a positive score. The resulting table was formatted and visualized using CytoScape (Shannon et
al., 2003). This type of plot permits color-codes positive and negative interplays; additionally, the
interplay score can define by the width of the lines (Figure 3.6A). For simplicity we only showed 50
interplay scores in the ring plot. Relative abundance can also be visualized using bar graphs as
shown in Figure 3.6B.
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Figure 3.6. Data visualization. Figures A and B show examples of data representation, visualized
as a ring plot (A) using Cytoscape or bar graph (B) using Excel. In the ring plot, the green lines
indicate negative interplay and the magenta lines indicate positive interplay. The thickness of the
lines is directly related to the value of the absolute interplay score: the thicker the line, the higher
the interplay score.

3.3 Discussion

Middle-down proteomics has emerged as the method of choice to study combinatorial
histone post translational modifications (PTMs). In the common bottom-up workflow, histones are
digested into relatively short peptides (4-20 aa), separated using reversed-phase chromatography
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and analyzed using typical proteomics methods in mass spectrometry. In middle-down, histones
are cleaved into longer polypeptides (50-60 aa) mostly corresponding to their N-terminal tails,
resolved using weak cation exchange-hydrophilic interaction liquid chromatography (WCX-HILIC)
and analyzed with less conventional mass spectrometry, i.e. using Electron Transfer Dissociation
(ETD) for analyte fragmentation. Middle-down is not nearly as utilized as bottom-up for PTM
analysis, partially due to its limited reproducibility and robustness. This has also limited the
establishment of rigorous benchmarks to discriminate good vs poor quality experiments. Here, we
describe critical aspects of the middle-down workflow, specifically, we tested the use of porous
graphitic carbon (PGC) during the desalting step, demonstrating that desalting using only C18
material leads to sample loss. We also tested different salts in the WCX-HILIC buffers for their
effect on retention, selectivity, and reproducibility of analysis of variants of histone tail fragments,
in particular replacing ammonium ion with ethylenediammonium ion in buffer A. These substitutions
had marked effects on selectivity and retention. Some significant new procedures and observations
are as follows:
a) During the desalting step, deposition of PGC resin on top of the C18 disk significantly
increased the number of isoforms identified (Figure 3.2A). This reflects PGC’s
complementary selectivity, especially for retention of polar solutes (Lunn et al., 2017).
When compared to bottom-up quantification values (Figure 3.2B), samples desalted with
PGC + C18 showed higher correlation than those desalted using C18 only.
b) One of the major limitations of this type of experiment is the lack of reproducibility, mainly
due to properties of the chromatography. Substitution of ethylenediammonium ion for
ammonium ion in Buffer A results in better reproducibility. In addition, the number of H3
isoforms identified is higher and there is better separation of H3 acetylation variants (Figure
3.3). This has interesting implications for the mechanism of the chromatography. When
ammonium ion is used, the varied affinity for the numerous positional and methylation
variants of various PTM’s results in appreciable overlap of forms differing in the number of
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acetylated lysine residues. Elimination of that overlap with ethylenediammonium ion
implies a shift in chromatographic selectivity to favor variants differing in absolute charge.

Here we have highlighted the utilization of 0.1% FA as buffer for HILIC-based
chromatography. We also provide detailed information on how to evaluate the performance of
middle-down analysis at the MS/MS level. Examples are provided of successful (Figure 3.4A) and
unsuccessful (Figure 3.4B) fragmentation, and possible reasons for insufficient fragmentation
(Figure 3.4C and D).

3.4 Materials and methods

3.4.1 Sample preparation and digestion with GluC

All the protocols and experiments presented here were performed utilizing a bovine histone
mixture, purchased from Sigma-Aldrich. The histone samples were digested with GluC to generate
large polypeptides spanning the first 50 amino acids of histone H3. To avoid subjecting GluC
solutions to freeze-thaw cycles, aliquots of 5 µg of were lyophilized using a vacuum centrifuge, and
these dried aliquots can be stored at -20° C for several months. In this study, 50 µg of histones
were digested in 5mM ammonium acetate pH 4.0 with GluC (1:20 ratio of enzyme:histone)
overnight at room temperature. The digestion can be incubated for 6 hours at 37° C or overnight at
room temperature. Importantly, GluC is active at around two different pH; at pH 8, it cleaves at the
C-termini of glutamic acid residues (E), while at pH 4 it cleaves at the C-termini of aspartic and
glutamic acid (DE). We recommend utilizing pH 4.0, because aspartic acid residues are not present
in the histone tail and lower pH minimizes deamination events (N à D or Q à E).
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3.4.2 Sample desalting by StageTips

The StageTips were made in-house, and all solvents listed used here were MS grade. The
StageTips were made by punching C18 extraction disks using a P1000 pipette tip, and then housed
into a p200 pipette (Lin and Garcia, 2012). Approximately 70 µl of Porous Graphitic Carbon resin
(PGC, HyperCarb® Thermo) were added on top of the C18 disk. Before adding it to the C18 disk
the PGC resin was mixed 1:1 with 100% acetonitrile. StageTips were centrifuged for 2 minutes at
200g, once the ACN passed through the C18 disk, and the flow through was discarded. Next,
StageTips were washed twice with 50 µl of 0.1% TFA. Samples were resuspended in 100 µl of
0.1% TFA and loaded into the StageTips. After 2 washes with 50 µl of water, samples were eluted
twice into a new microcentrifuge with 50 µl of elution buffer, which is the same as the WCX-HILIC
buffer A (70% acetonitrile, 20 mM propionic acid pH 6.0, adjusted using ethylenediamine). The
eluted samples are now ready for MS analysis.

3.4.3. Nano LC (nLC) configuration for middle-down

After desalting, samples (2 µg) were loaded onto a 75um ID silica capillary packed with
PolyCAT A (PolyLC Inc; Columbia, MD), 1.9-µm, with 1000-Å pores. Histone tails were eluted over
90 minute using a non-linear gradient from 0-72 %B in 2 min, followed by 72-85% B. Buffer A
consisted of 70% ACN, 20mM propionic acid pH 6 (using ethylenediamine to adjust pH), Buffer B
was 0.1% FA solution in water. The flow rate used to deliver the gradient was set to 300 nl/min. All
buffers were prepared using MS grade solvents.

3.4.4 MS/MS analysis

Data was acquired in data dependent mode (DDA) using a hybrid Orbitrap Fusion mass
spectrometer (Thermo). We programmed the MS acquisition method using high resolution for both
full MS (MS1) event and tandem MS (MS2) scans. A full mass spectrum was acquired at a narrow
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scan range (665-705 m/z) to select for histone H3 peptides with a charge state of +8, as these
histone peptides have the most intense ionization frequency, and the H3 peptides are the least
crowded. Additionally, a charge gate filter was also added to include charge state +8 to target for
fragmentation. Dynamic exclusion was used to exclude peaks for 2 sec so more data could be
obtained on less intense peaks that co-elute. More detailed parameters for the MS1 and MS2 scans
are listed in Table 1. Ion transfer tube temperature was set to 300° C and the spray voltage was
set to 2.3kV. Finally, 3 microscans were averaged to obtain a high-resolution spectrum.

Table 1. Mass spectrometer parameters for precursor and fragment ions identification.
Parameter

MS 1

MS 2

Resolution

Orbitrap - 120000

Orbitrap - 30000

Fragmentation

-

ETD
20ms reaction time

AGC target

2.0e5

2.0e5

Ion injection time

100

800

3.4.5 Data analysis

After data acquisition, MS raw files were searched using Mascot 2.5 against histone
databases, UniProt (2014). Before the database search, the MS raw files were deconvoluted using
Xtract (Thermo). For database search, dynamic modifications: Acetylation (K), mono and
dimethylation (RK), and trimethylation (K) were included. The mass tolerance was set to 2.1 Da for
the precursor ions and 0.01 Da for the fragment ions. The resulting Mascot search files were
downloaded as comma separated values (.csv) and the query information included. The csv file
was further processed using our in-house software IsoScale (Greer et al., 2018) freely available at
http://middle-down.github.io/Software/. IsoScale discards ambiguously mapped PTMs, providing
highly confident quantification and identification.
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CHAPTER 4: Conclusions and future directions

4.1: Summary and main findings

This dissertation presents the work I have completed to demonstrate the role of histone
proteolysis during stem cell differentiation (Chapter 2). As well as methodological improvements to
the middle-down-MS platform for histone analysis (Chapter 3). It is of importance to note that mass
spectrometry (MS)-based approaches are widely used in the epigenetics field to interrogate
chromatin biology. In addition to quantification and identification of histone PTMs, it has been
employed to determine the rate of histone PTMs turnover (Sidoli et al., 2017), to study chromatin
compaction (Sidoli et al., 2019; Stransky et al., 2020) and to assess nucleosome dynamics (Karch
et al., 2018). Moreover, affinity-based approaches have been coupled to MS to identify readers of
histone PTMs and chromatin binding proteins (Wierer and Mann, 2016), highlighting the vast
utilization of MS-based proteomics in the epigenetics field. Through the second chapter of this
dissertation I utilized MS to decipher the role of histone proteolysis during ESCs differentiation. My
studies demonstrated the following main findings:
1: Histone H2A is cleaved during ESCs differentiation at L23 by the lysosomal protease
Cathepsin L. Previous studies have shown that histone H2A is cleaved at the C-terminus in
different biological contexts (Dhaenens et al., 2014; Glibert et al., 2014). Similarly, studies have
demonstrated that during development histone H3 has been shown to be cleaved by Cathepsin L
(Duncan et al., 2008) however, whether other histones can undergo proteolysis during
differentiation was unknown. Here I determined that histone H2A is cleaved at L23 (cH2A) upon
ESCs differentiation, which reaches a maximum level of ~1% of total H2A after 4 days of
differentiation. Furthermore, knockdown (KD) of Cathepsin L showed significant reduction (3-fold
decreased) of cH2A, indicating that Cathepsin L facilitates H2A proteolysis.
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2.

Histone proteolysis served to silence pluripotency-related genes.

Upon

differentiation H2A is dynamically acetylated at the N-terminus, specifically at K5 and K9. My
studies using chromatin immunoprecipitation followed by sequencing (ChIP-seq) showed that KD
of Cathepsin L leads to genome wide redistribution of acetylated H2A, specifically after four days
of embryoid bodies (EBs) formation, where the occupancy of H2AK9ac at promoter regions
increases by 4% in KD Cathepsin L cells. Using whole transcriptomic analysis (RNA-seq) I found
that genes that acquired H2AK9ac upon KD of Cathepsin L are typically low expressed genes
involved in pluripotency. Previous work has shown that during cellular senescence H3.3 proteolysis
has been reported to silence cell cycle genes (Duarte et al., 2014). Here my studies showed that
H2A proteolysis aids in gene regulation by silencing genes involve in self renewal and pluripotency

3. PBAF complex recognizes acetylated H2A, however upon proteolysis this recognition is
impaired. Using affinity-based approaches, I established for the first time that members of the PBAF
complex recognize acetylated H2A. The PBAF chromatin remodeler complex has been shown to
be critical for pluripotency maintenance (Hiramatsu et al., 2017; Kidder et al., 2009). This complex
(~ 1.5MDa) comprises more than 15 subunits some of which have histone PTMs recognition motifs
such as bromo and PHD domains. In fact, members of this complex have been reported to bind
H3K4me1 (A et al., 2017) and H3K14ac (Porter and Dykhuizen, 2017). My data showed that
members of the PBAF (Brd7, Brg1, Pbrm1) recognize different forms of acetylated H2A and have
higher affinity for the dual mark, H2AK5acK9ac. Additionally, utilizing immuno-affinity precipitation
followed by MS (IP-MS) I found that FL-H2A but not cH2A is able to interact with the PBAF
complex, suggesting that H2A proteolysis diminished PBAF recognition to acetylated H2A.

4. Histone proteolysis destabilize the nucleosome in vivo. Previous studies have found that
nucleosome tails are unstable in vitro (Nurse et al., 2013). To assess the nucleosome stability in
vivo, I performed protein degradation studies. After blocking protein synthesis with cycloheximide,
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I found that FL-H2A was stable for eight hours, but cH2A was rapidly degraded, suggesting that
proteolysis may promote nucleosome eviction.

In conclusion, my findings shed light to the significance of histone proteolysis, a poorly
understood phenomena in chromatin biology. Here I proposed that Cathepsin L mediates the
proteolysis of H2A to remove acetylation on the N-terminal tail, thereby silencing genes involved in
the maintenance of pluripotency. For extended discussion of this topic, please refer to the
discussion section of chapter 2 (pages 40-44).

In chapter 3 I highlight the work I have done to improve the current middle-down platform
(Coradin et al., 2020). To study histone PTM crosstalk and co-existing modifications in histone
tails. middle-down MS is the method of choice. Compared to antibody based-method, middle-down
allows for unbiased identification of combinatorial PTMs. However, compared to bottom-up MS,
middle-down tends to be less reproducible and more labor intense. Overcoming these hindrances,
my efforts to improve to the middle-down workflow revealed the following findings:

1.

The use of porous graphitic carbon (PGC) in the desalting step reduced sample loss during
sample preparation. This is achieved due to the ability of PGC to retain polar solutes. The
reduction of sample lost is critical due to the large sample requirement for middle-down
experiments (50ug).

2.

Incorporation of ethylenediammonium salts for buffer A in liquid chromatography aids the
separation of H3 isoforms and increases reproducibility. Traditionally, buffer A contains
ammonium hydroxide (NH4OH); however, ethylenediammonium ion forms better hydrated
ion pairs with the acidic residues in histones (Alpert, 2018), resulting in better separation
of H3 isoforms and ultimately increasing reproducibility of middle-down analysis.
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3. My work provides a simplified way to evaluate middle-down performance to identify and
quantify combinatorial histone PTMs.

Beyond the work presented in chapter 3, I made significant contributions to three particular
studies applying middle-down MS to expand the proteomics toolkit. In the first study, we combined
middle-down proteomics with metabolic labeling to quantify combinatorial PTMs in a dynamic
fashion (Sidoli et al., 2017). Secondly, we demonstrate that the utilization of PGC as stationary
phase can be used to replace the traditional WCX-HILIC (Janssen et al., 2019). Finally, we
employed middle-down MS combined with hydrogen-deuterium exchange to assess histone
stability before and after nucleosome deposition (Karch et al., 2018).

4.2: Future directions
The studies presented in chapter 2 significantly increased our knowledge and
understanding on the role of histone H2A proteolysis during stem cell differentiation. My work has
demonstrated that histone H2A proteolysis aids cellular differentiation by silencing pluripotency
related genes. Yet, other unanswered questions remain. In the next sections, I will describe open
questions and potential follow up experiments to address them.

4.2.1 Histone proteolysis on H2A variants
Histone H2A is known to contain the largest number of variants, compared to H3 and H2B
(Bönisch and Hake, 2012). Some variants such as H2A.Z, H2A.X H2A.Bdb and macroH2A differ
from the canonical H2A at the C-terminal tail both length and sequence (Nashun et al., 2010).
These variants are known to be dynamically regulated during development, macroH2A for example
is known to be highly expressed in differentiated cells, compared to H2A.Z which is highly express
at the blastocyte stage (Santoro and Dulac, 2015). While the role of these variants in gene silencing
and nucleosome dynamics are well characterized, it remains to be determined if they are cleaved
during differentiation or other biological processes. If these variants are indeed cleaved, it will be
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interesting to identify the proteases that facilitate the cleavage. This can be tested by establishing
a differentiation system that allow for enrichment of these variants at different time points, and then
MS can be used to study these different H2A variants. Protease identification can be done by
affinity pull-down experiments followed by MS analysis. Addressing this question will further expand
our knowledge on histone H2A variants during development.

4.2.2: Cathepsin L recruitment to chromatin in ESCs
Cathepsin L is a lysosomal protease that has been shown to localized to the nucleus
where it cleaves the transcription factor CDP-Cux (Goulet et al., 2004), H3 (Duncan et al., 2008),
H3.3 (Duarte et al., 2014) and H2A (chapter 2). Cathepsin L lacks histone PTMs recognition
domains such as bromo or chromo domains, so it is unclear how does it gets recruited to chromatin.
One hypothesis is that Cathepsin L is recruited to hyperacetylated chromatin domains to facilitate
rapid gene silencing. To test this, first the genome wide localization of Cathepsin L needs to be
established, which can be determined ChIP-seq. This represents a challenge due to (1) the lack of
a Cathepsin L ChIP-seq quality antibody and (2) the rapid kinetics of this enzyme. To tackle this,
the introduction of a catalytically dead mutant of Cathepsin L expressing a tag (FLAG or HA) can
increase the IP efficiency and circumvent the requirement of sequencing grade antibody against
Cathepsin L. Next, ChIP-seq of different acetyls marks (H3K14ac, H2AK9ac, H2AK5ac, H3K27ac,
acH4) will be necessary to determine whether Cathepsin L is found at hyperacetylated regions.
It is also possible that Cathepsin L interacts with other chromatin binding proteins to
regulate gene expression during development. It will be fascinating to establish Cathepsin L
interacting partners in undifferentiated ESCs as well as differentiated cells. This can be achieved
by IP-MS using ectopically tagged Cathepsin L. These studies should be focused on nuclear
cathepsin L to distinguish its lysosomal and nuclear functions. Understanding how this protease
gets recruited to specific genomic locations can further broaden the current knowledge

in

proteolysis and chromatin proteases. Similar studies can be applied to other members of the
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Cathepsin family such as Cathepsin D and Cathepsin B which have also been shown to localized
in the nucleus (Bach et al., 2015; Tamhane et al., 2016).

4.2.3: Genome wide localization of PBAF upon proteolysis
Another outstanding question is how does the genome wide localization of PBAF changes
upon histone H2A proteolysis. As discussed in chapter 2, my findings showed that acetylated H2A
is recognized by members of the PBAF complex in undifferentiated cells. PBAF not only binds
acetylated H2A, but also H3K4me1 (A et al., 2017) and H3K14ac (Porter and Dykhuizen, 2017).
My findings also demostrated that the recognition of acetylated H2A by PBAF is diminished upon
proteolysis suggesting that perhaps the genomic localization of PBAF is also compromised upon
proteolysis, therefore it will be crucial to decipher how H2A proteolysis alter the genome wide
distribution of PBAF through differentiation. PBAF is critical for self-renewal and pluripotency
(Kidder et al., 2009). Furthermore, upon ESCs differentiation, the PBAF undergoes subunit
exchange to regulate cell identity, (Kadoch and Crabtree, 2015). To date only a few subunits of
this complex have been characterized by ChIP-seq in the context of ESCs differentiation
(Alexander et al., 2015). Therefore, performing ChIP-seq for members of the BAF complex that
remained unchanged during development in ESCs WT and KD cells for Cathepsin L, can help to
answer this question and broaden the implications of histone proteolysis during development.

4.2.4: What happens after nucleosome eviction?
Histone tails are critical components of nucleosomes and their proteolysis has been shown
to destabilize the nucleosome in vitro (Nurse et al., 2013). My studies showed that H2A proteolysis
by Cathepsin L destabilizes nucleosomes in vivo, suggesting that proteolysis may promote
nucleosome eviction, yet the downstream consequence of nucleosome eviction remain to be
explored. One hypothesis is that nucleosome eviction leads to nucleosome depleted regions
(NDR), these regions are known to be present at transcription start sites (TSS) and enhancers (You
et al., 2011). This can be tested using the assay for transposase-accessible chromatin using
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sequencing (ATAC-seq) during differentiation in WT and KD cells for Cathepsin L. This experiment
has the ability to provide spatiotemporal information of chromatin accessibility before and after
histone proteolysis. Alternatively, nucleosome eviction could lead to the replacement of cH2A with
a newly synthesize H2A or an H2A variant, although this will be more challenging to test, a largescale ChIP-seq experiment for several H2A variants can provide insights about variant deposition
prior to proteolysis.

4.2.4 New developments in Middle-Down MS

The third chapter of this dissertation focused on my efforts to optimize the current middledown platform, yet there is still room for improvements. From the chromatographic standpoint,
WCX-HILIC chromatography set up can be labor intensive and not available for most MS
proteomics laboratories.

The Yi lab, developed a derivatization method using N-

hydroxysuccinimide before GluC digestion to increase the separation efficiency of H3 tails using
C18 based chromatography (Liao et al., 2017). Others have opted for Neoprosin instead of GluC
to digest histone tails, and this enzyme generated peptides from 1-38AA which can be resolved
with C18-based chromatography (Schräder et al., 2018). Recently, a new software to visualize
PTMs crosstalk was introduced by Kirsch and colleagues (Kirsch et al., 2020). Taken together,
these studies will allow proteomics laboratories to performed middle-down MS just as frequent as
bottom-up. As shown in Figure 4.1 the number of publications containing middle-down MS have
increased over the last ten years. I predict that with the new developments in middle-down MS,
these numbers will continue increasing.
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Figure 4.1 Middle-down MS in literature. Data obtained from PubMed.

98

4.3. References
A, L., H, H., Cp, A., N, S., Ay, L., W, W., C, W., Je, H., Ak, S., K, G., et al. (2017).
Identification of H3K4me1-associated proteins at mammalian enhancers. Nat. Genet. 50, 73–82.
Alexander, J.M., Hota, S.K., He, D., Thomas, S., Ho, L., Pennacchio, L.A., and Bruneau,
B.G. (2015). Brg1 modulates enhancer activation in mesoderm lineage commitment. Dev. Camb.
Engl. 142, 1418–1430.
Alpert, A.J. (2018). Effect of salts on retention in hydrophilic interaction chromatography.
J. Chromatogr. A 1538, 45–53.
Bach, A.-S., Derocq, D., Laurent-Matha, V., Montcourrier, P., Sebti, S., Orsetti, B., Theillet,
C., Gongora, C., Pattingre, S., Ibing, E., et al. (2015). Nuclear cathepsin D enhances TRPS1
transcriptional repressor function to regulate cell cycle progression and transformation in human
breast cancer cells. Oncotarget 6, 28084–28103.
Bönisch, C., and Hake, S.B. (2012). Histone H2A variants in nucleosomes and chromatin:
more or less stable? Nucleic Acids Res. 40, 10719–10741.
Coradin, M., Mendoza, M.R., Sidoli, S., Alpert, A.J., Lu, C., and Garcia, B.A. (2020). Bullet
points to evaluate the performance of the middle-down proteomics workflow for histone modification
analysis. Methods 184, 86–92.
Dhaenens, M., Glibert, P., Lambrecht, S., Vossaert, L., Van Steendam, K., Elewaut, D.,
and Deforce, D. (2014). Neutrophil Elastase in the capacity of the “H2A-specific protease.” Int. J.
Biochem. Cell Biol. 51, 39–44.
Duarte, L.F., Young, A.R.J., Wang, Z., Wu, H.-A., Panda, T., Kou, Y., Kapoor, A., Hasson,
D., Mills, N.R., Ma’ayan, A., et al. (2014). Histone H3.3 and its proteolytically processed form drive
a cellular senescence programme. Nat. Commun. 5, 5210.
Duncan, E.M., Muratore-Schroeder, T.L., Cook, R.G., Garcia, B.A., Shabanowitz, J., Hunt,
D.F., and Allis, C.D. (2008). Cathepsin L Proteolytically Processes Histone H3 During Mouse
Embryonic Stem Cell Differentiation. Cell 135, 284–294.

99

Glibert, P., Vossaert, L., Van Steendam, K., Lambrecht, S., Van Nieuwerburgh, F., Offner,
F., Kipps, T., Dhaenens, M., and Deforce, D. (2014). Quantitative Proteomics to Characterize
Specific Histone H2A Proteolysis in Chronic Lymphocytic Leukemia and the Myeloid THP-1 Cell
Line. Int. J. Mol. Sci. 15, 9407–9421.
Goulet, B., Baruch, A., Moon, N.-S., Poirier, M., Sansregret, L.L., Erickson, A., Bogyo, M.,
and Nepveu, A. (2004). A Cathepsin L Isoform that Is Devoid of a Signal Peptide Localizes to the
Nucleus in S Phase and Processes the CDP/Cux Transcription Factor. Mol. Cell 14, 207–219.
Hiramatsu, H., Kobayashi, K., Kobayashi, K., Haraguchi, T., Ino, Y., Todo, T., and Iba, H.
(2017). The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of
glioma initiating cells. Sci. Rep. 7, 889.
Janssen, K.A., Coradin, M., Lu, C., Sidoli, S., and Garcia, B.A. (2019). Quantitation of
Single and Combinatorial Histone Modifications by Integrated Chromatography of Bottom-up
Peptides and Middle-down Polypeptide Tails. J. Am. Soc. Mass Spectrom. 30, 2449–2459.
Kadoch, C., and Crabtree, G.R. (2015). Mammalian SWI/SNF chromatin remodeling
complexes and cancer: Mechanistic insights gained from human genomics. Sci. Adv. 1, e1500447.
Karch, K.R., Coradin, M., Zandarashvili, L., Kan, Z.-Y., Gerace, M., Englander, S.W., Black,
B.E., and Garcia, B.A. (2018). Hydrogen-Deuterium Exchange Coupled to Top- and Middle-Down
Mass Spectrometry Reveals Histone Tail Dynamics before and after Nucleosome Assembly. Struct.
Lond. Engl. 1993 26, 1651-1663.e3.
Kidder, B.L., Palmer, S., and Knott, J.G. (2009). SWI/SNF-Brg1 regulates self-renewal and
occupies core pluripotency-related genes in embryonic stem cells. Stem Cells Dayt. Ohio 27, 317–
328.
Kirsch, R., Jensen, O.N., and Schwämmle, V. (2020). Visualization of the dynamics of
histone modifications and their crosstalk using PTM-CrossTalkMapper. Methods San Diego Calif.
Liao, R., Zheng, D., Nie, A., Zhou, S., Deng, H., Gao, Y., Yang, P., Yu, Y., Tan, L., Qi, W.,
et al. (2017). Sensitive and Precise Characterization of Combinatorial Histone Modifications by
Selective Derivatization Coupled with RPLC-EThcD-MS/MS. J. Proteome Res. 16, 780–787.

100

Nashun, B., Yukawa, M., Liu, H., Akiyama, T., and Aoki, F. (2010). Changes in the nuclear
deposition of histone H2A variants during pre-implantation development in mice. Development 137,
3785–3794.
Nurse, N.P., Jimenez-Useche, I., Smith, I.T., and Yuan, C. (2013). Clipping of Flexible Tails
of Histones H3 and H4 Affects the Structure and Dynamics of the Nucleosome. Biophys. J. 104,
1081–1088.
Porter, E.G., and Dykhuizen, E.C. (2017). Individual Bromodomains of Polybromo-1
Contribute to Chromatin Association and Tumor Suppression in Clear Cell Renal Carcinoma. J.
Biol. Chem. 292, 2601–2610.
Santoro, S.W., and Dulac, C. (2015). Histone variants and cellular plasticity. Trends Genet.
31, 516–527.
Schräder, C.U., Ziemianowicz, D.S., Merx, K., and Schriemer, D.C. (2018). Simultaneous
Proteoform Analysis of Histones H3 and H4 with a Simplified Middle-Down Proteomics Method.
Anal. Chem. 90, 3083–3090.
Sidoli, S., Lu, C., Coradin, M., Wang, X., Karch, K.R., Ruminowicz, C., and Garcia, B.A.
(2017). Metabolic labeling in middle-down proteomics allows for investigation of the dynamics of
the histone code. Epigenetics Chromatin 10.
Sidoli, S., Lopes, M., Lund, P.J., Goldman, N., Fasolino, M., Coradin, M., Kulej, K., Bhanu,
N.V., Vahedi, G., and Garcia, B.A. (2019). A mass spectrometry-based assay using metabolic
labeling to rapidly monitor chromatin accessibility of modified histone proteins. Sci. Rep. 9, 13613.
Stransky, S., Aguilan, J., Lachowicz, J., Madrid-Aliste, C., Nieves, E., and Sidoli, S. (2020).
Mass Spectrometry to Study Chromatin Compaction. Biology 9.
Tamhane, T., lllukkumbura, R., Lu, S., Maelandsmo, G.M., Haugen, M.H., and Brix, K.
(2016). Nuclear cathepsin L activity is required for cell cycle progression of colorectal carcinoma
cells. Biochimie 122, 208–218.
Wierer, M., and Mann, M. (2016). Proteomics to study DNA-bound and chromatinassociated gene regulatory complexes. Hum. Mol. Genet. 25, R106–R114.

101

You, J.S., Kelly, T.K., Carvalho, D.D.D., Taberlay, P.C., Liang, G., and Jones, P.A. (2011).
OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of
epigenetic regulation of its target genes. Proc. Natl. Acad. Sci. 108, 14497–14502.

102

